Skip to main content
Korean Circulation Journal logoLink to Korean Circulation Journal
. 2015 Mar 24;45(2):141–148. doi: 10.4070/kcj.2015.45.2.141

Effects of Age, Sex, and Menopausal Status on Blood Cholesterol Profile in the Korean Population

Ji Hye Park 1, Myung Ha Lee 2, Jee-Seon Shim 3, Dong Phil Choi 1, Bo Mi Song 1, Seung Won Lee 1, Hansol Choi 1, Hyeon Chang Kim 2,3,
PMCID: PMC4372980  PMID: 25810736

Abstract

Background and Objectives

To investigate age-specific and sex-specific distributions of blood cholesterol in the general Korean population.

Subjects and Methods

We analyzed data for 8284 men and 9246 women aged ≥10 years who participated in the fifth (2010-2012) Korea National Health and Nutrition Examination Survey. Age-specific means, medians, and selected percentiles were calculated for men, premenopausal women, and postmenopausal women.

Results

Median total cholesterol (TC) level increased with age across all age groups, from 147 to 196 mg/dL in males and from 159 to 210 mg/dL in females. Triglyceride (TG) levels increased with age in females; however, in males, TG levels rapidly increased during young adulthood, peaked at 50-54 years, and then decreased. High density lipoprotein-cholesterol (HDL-C) levels were higher in females than in males and decreased with increasing age in both males and females. Low density lipoprotein-cholesterol (LDL-C) levels increased with age across all age groups, from 89 to 127 mg/dL in males and from 82 to 113 mg/dL in females. Lipoprotein-cholesterol fraction (TC/HDL-C, LDL-C/HDL-C, TG/HDL-C, non-HDL-C) levels increased with age in females, but increased more rapidly in males during young adulthood and decreased after middle age.

Conclusion

Blood cholesterol levels and lipoprotein-cholesterol fractions present different distributions by age, sex, and menopausal status.

Keywords: Cholesterol, Triglycerides, High density lipoprotein-cholesterol, Low density lipoprotein-cholesterol, Epidemiology

Introduction

Cardiovascular disease is the leading cause of death in Korea, and its burden on society is steadily increasing due to an ageing population and worsening cardiovascular risk profiles. Elevation or imbalance in blood cholesterols is the most important cardiovascular risk factor. High levels of total cholesterol (TC) and low density lipoprotein-cholesterol (LDL-C) are recognized as significant contributing factors to atherosclerotic cardiovascular disease,1),2) and elevated low serum high density lipoprotein-cholesterol (HDL-C) is asso-ciated with increased risk of cardiovascular disease.3),4) Ratios of li-poprotein-cholesterol fractions, such as TC to HDL-C ratio (TC/HDL-C) or LDL-C to HDL-C ratio (LDL-C/HDL-C), are better than the ab-solute level of LDL-C at discriminating between individuals who are more or less likely to develop cardiovascular disease based on the results from previous studies.3),5),6) Thus, TC/HDL-C or LDL-C to HDL-C ratio (LDL-C/HDL-C) may prove to be a better marker for identifying and monitoring cardiovascular disease risk.7) Increasing evidence8),9) supports the theory that serum triglycerides (TG) may be an independent risk factor for cardiovascular disease. Moreover, elevated TG and low HDL-C are basic characteristics of insulin resistance and metabolic syndrome, which are both strongly associated with cardiovascular disease.10),11) The TG/HDL-C, a relatively novel lipoprotein index, could serve as a good predictor of cardiovascular disease.12) At the same time, the non-HDL-C (calculated by subtracting HDL-C from TC) level provides a convenient measure of the cholesterol content of all atherogenic lipoproteins, and thus incorporates the potential risk for cardiovascular disease.13)

Many studies have investigated the prevalence of dyslipidemia.14),15),16) However, to date, no study has yet reported on the distributions of plasma lipid and lipoprotein-cholesterol fractions by age, sex, and menopausal status of Korean participants. Therefore, we investigated the distributions of TC, TG, HDL-C, LDL-C, and lipoprotein-cholesterol fractions according to age, sex and menopausal status in the Korean population.

Subjects and Methods

Participants

This study was based on data obtained from the fifth (2010-2012) Korean National Health and Nutritional Examination Survey (KNHANES). The KNHANES is performed annually with a stratified multistage probability cluster sample, which is designed to be representative of the entire population of South Korea.17) A total of 25534 individuals participated in the fifth KNHANES. Among these participants, we excluded individuals as follows: 1) aged <10 years; 2) taking lipid-lowering agents; 3) use of hormone replacement therapy within the last 12 months; and 4) lipid profiles that were not available. Finally, a total of 17530 subjects (8284 men and 9246 women) were analyzed for this study. Written informed consent was secured from each participant, and the KNHANES was conducted after ethical approval by the Institutional Review Board of the Korean Centers for Disease Control and Prevention (approval no. 2010-02CON-21-C, 2011-02CON-06-C, 2012-01EXP-01-2C).

Measurements

Blood samples were taken after subjects had fasted for eight or more hours. Fasting blood samples collected from each individual during the survey were processed, refrigerated immediately, transported in cold storage to the central laboratory (Neodin Medical Institute, Seoul, Korea), and analyzed within 24 hours after transportation. Fasting glucose, TC, HDL-C, and TG levels were determined using a Hitachi 7600 automated chemistry analyzer (Hitachi, Tokyo, Japan). The Friedewald formula was used to calculate LDL-C for subjects with serum TG level ≤400 mg/dL18) and measured directly using the Hitachi 7600 analyzer for subjects with serum TG level >400 mg/dL. Non-HDL-C was calculated by subtracting HDL-C from TC. Hypertension, diabetes, and dyslipidemia were defined as the cases where the participants replied that they had been diagnosed by a physician in the health interview survey. The health interview survey asked the female participants whether they were currently menmenstruating, then asked the cause of absent menstruation if they answered no. Menopausal status was dichotomized into premeno-pausal versus postmenopausal states, which included menopause with or without a hysterectomy. Body mass index was calculated by dividing weight by height (kg/m2). Smoking status was categorized into never/past or current (daily or intermittent) smoker. Alcohol consumption was categorized according to the frequency of alcohol consumed, and alcohol drinkers were defined as those who consume more than drinks at least once per month.

Statistical analyses

Mean, standard deviation, and selected percentile values were calculated for each variable by age, sex, and menopausal status. St-atistical analyses were conducted using Statistical Analysis System (SAS) version 9.2 (SAS Institute, Cary, NC, USA) and with the consideration of a two-sided p less than 0.05 as statistically significant for all analyses.

Results

Characteristics of the study population are shown in Table 1. Pre-valence of previously diagnosed hypertension, diabetes, and dyslipidemia was 18.6%, 7.9%, and 7.9% in males, and 20.1%, 6.3%, and 10.5% in females, respectively. Males had significantly higher blood pressure, fasting glucose, TG, and history of smoking and drinking than females. Distributions of lipid levels and lipoprotein-cholesterol fractions are presented by 5-year age intervals in the tables and figures. Supplementary Table 1, 2, 3, 4, 5, 6, 7, 8 contain the number of subjects, means, standard deviations of the means, and percentile values; figures contain only medians for each variable.

Table 1. General characteristics of study population.

Variables Male (n=8284) Female (n=9246) p
Age (year) 44.4±19.9 44.1±19.1 0.462
Height (cm) 168.8±8.2 156.9±6.9 <0.001
Weight (kg) 67.1±12.6 56.2±9.7 <0.001
Body mass index (kg/m2) 23.4±3.4 22.8±3.6 <0.001
Waist circumference (cm) 82.1±10.4 76.6±10.4 <0.001
Systolic blood pressure (mm Hg) 120.0±16.0 115.1±17.6 <0.001
Diastolic blood pressure (mm Hg) 77.0±11.6 72.8±10.1 <0.001
Fasting glucose (mg/dL) 93 [87-101] 90 [85-97] <0.001
HbA1c (%) 5.8±0.9 5.7±0.8 <0.001
Total cholesterol (mg/dL) 182.8±36.1 187.8±36.5 <0.001
HDL-C (mg/dL) 49.9±11.9 55.4±12.6 <0.001
Triglycerides (mg/dL) 111 [74-167] 88 [62-131] <0.001
Known hypertension (%) 1324 (20.0) 1451 (15.7) <0.001
Known diabetes (%) 547 (6.6) 435 (4.7) <0.001
Known dyslipidemia (%) 303 (3.7) 329 (3.6) 0.424
Current smoker (%) 2812 (45.4) 462 (5.0) <0.001
Alcohol drinker (%) 4191 (50.6) 3108 (33.6) <0.001

Data are expressed as means±standard deviation, median [inter quartile range]. HbA1c: hemoglobin A1c, HDL-C: high density lipoprotein-cholesterol

The level of TC increased from 156 mg/dL in the males 10-14 years old to a maximum of 196 mg/dL in the 50-54 year age group, and in females these levels increased from 163 mg/dL in 10-14 year olds to a maximum of 210 mg/dL in 55-59 year olds. Between age 25 to 49 years, TC level was higher in males than in females. However, the TC level was higher in females than in males among the younger (10 to 19 years) and older (≥50 years) age groups (Fig. 1, Supplementary Table 1 and 2 in the online-only Data Supplement).

Fig. 1. Median values of total cholesterol for age, sex, and menopausal status.

Fig. 1

The level of TG increased with age and peaked among females aged ≥80 years, while the males reflected a more rapid increase of plasma TG levels during young adulthood (10 to 54 years) which decreased during middle age (55 to ≥80 years). The highest TG level was observed in 50-54 year (138 mg/dL) old males, and 65-69 years (124 mg/dL) in females. Between age 15 to 64 years, TG level was higher in males, but , higher in females after age 65 (Fig. 2, Supplementary Table 3 and 4 in the online-only Data Supplement).

Fig. 2. Median values of triglycerides for age, sex, and menopausal status.

Fig. 2

The level of HDL-C were compared between males and females. Females showed higher HDL-C levels than males in all age groups. The highest value was observed among 25-29 year olds (59 mg/dL), which was followed by a decrease (47 mg/dL for females ≥80 years). In males, the highest value was observed among 10-14 year olds (53 mg/dL), followed by a decrease (44 mg/dL for males ≥80 years). The HDL-C level in males decreased almost linearly, while a more rapid decrease of these levels during middle age was observed in females (Fig. 3, Supplementary Table 5 and 6 in the online-only Data Supplement).

Fig. 3. Median values of high density lipoprotein-cholesterol for age, sex, and menopausal status.

Fig. 3

The level of LDL-C revealed a pattern similar to TC levels. The cr-ossover of LDL-C levels for the sexes occurred in the 50-54 year age group and led to higher LDL-C values in females than in males over 50 years (Fig. 4, Supplementary Table 7 and 8 in the online-only Data Supplement).

Fig. 4. Median values of low density lipoprotein-cholesterol for age, sex, and menopausal status.

Fig. 4

The TC/HDL-C ratio rapidly increased from 2.85 in the males aged 10-14 to a maximum of 4.14 in the 45-49 year olds, while in females it increased from 2.97 in 10-14 year olds to a maximum of 4.16 in the ≥80 year group. The crossover of TC/HDL-C ratio for the sexes occurred in those aged 60-64 and led to a higher ratio in females compared to males older than 60 years (Fig. 5, Supplementary Table 9 and 10 in the online-only Data Supplement).

Fig. 5. Median values of TC/HDL-C ratio for age, sex, and menopausal status. TC: total cholesterol, HDL-C: high density lipoprotein-cholesterol.

Fig. 5

In males, the LDL-C/HDL-C ratio increased from 1.59 in 10-14 year olds to a maximum of 2.42 in 45-49 year old, while in females these values increased from 1.64 in 10-14 year olds to a maximum of 2.55 in 60-64 year olds. The crossover of LDL-C/HDL-C ratio for the sexes occurred in 55-59 year olds, which led to higher ratio in females than in males after 55 years (Fig. 6, Supplementary Table 11 and 12 in the online-only Data Supplement).

Fig. 6. Median values of LDL-C/HDL-C ratio for age, sex, and menopausal status. LDL-C: low density lipoprotein-cholesterol, HDL-C: high density lipoprotein-cholesterol.

Fig. 6

The TG/HDL-C ratio in males increased from 1.20 in 10-14 year olds to a maximum of 3.06 in 50-54 year olds, and in females these values increased from 1.40 in the 10-14 year olds to a maximum of 2.63 in those ≥80 years (Fig. 7, Supplementary Table 13 and 14 in the online-only Data Supplement).

Fig. 7. Median values of TG/HDL-C ratio for age, sex, and menopausal status. TG: triglycerides, HDL-C: high density lipoprotein-cholesterol.

Fig. 7

The value of non-HDL-C in males increased from 100 mg/dL in 10-14 year olds to a maximum of 146 mg/dL in 45-54 year olds. In females, these values increased from 106 mg/dL in 10-14 year olds to a maximum of 155.5 mg/dL in 55-59 year olds (Fig. 8, Supplementary Table 15 and 16 in the online-only Data Supplement).

Fig. 8. Median values of non-HDL-C for age, sex, and menopausal status. HDL-C: high density lipoprotein-cholesterol.

Fig. 8

Discussion

We reported the distributions of plasma lipid and lipoprotein-cholesterol fractions by sex and age among 17530 Koreans, which were sampled to represent the Korea population. These data are provided to facilitate the identification of individuals in the highest lipid or lipoprotein percentiles by age, sex, and menopausal status. Plasma lipid and lipoprotein-cholesterol fractions levels increased with age in females, while the males tend to have a more rapid increase during young adulthood and a decrease during and after middle age.

Blood lipid level and lipoprotein composition have a role in the development of atherogenesis and vascular disorders. Most importantly, the risk of atherosclerotic heart disease increases with increasing levels of TC and LDL-C;19) but the risk decreases with increasing levels of HDL-C.20),21) The age-related and sex-related ch-anges in LDL-C levels reported in this study closely resemble those for TC, as almost 70% of TC is transported by lipoproteins in the low-density range. When compared with US populations from the NHANES 2010,22) Korean males showed lower mean TC and LDL-C levels (TC 183 mg/dL; LDL-C 106 mg/dL) compared to American males (TC 194 mg/dL; LDL-C 116 mg/dL), and Korean females also showed lower mean levels (TC 188 mg/dL; LDL-C 111 mg/dL) than American females (TC 198 mg/dL; LDL-C 115 mg/dL). It is well-known that HDL-C is higher in females than in males.23) In our population, the mean HDL-C level was 50 mg/dL for males and 55 mg/dL for females. Korean males displayed higher HDL-C levels than American males (47 mg/dL), while levels in Korean females were lower than American females (57 mg/dL). Accordingly, male-female difference in mean HDL-C level is only 5 mg/dL in the Korean population, while it is about 10 mg/dL in the American population. The mean TG levels are consistently higher (males 134 mg/dL; female 107 mg/dL) than those found in previous surveys of the US populations (males 119 mg/dL; female 102 mg/dL). A high carbohydrate diet may be the one of the possible causes of high TG levels in the Korean population, which in turn promotes the formulation of small and dense LDLs.24) The reason for the difference in lipoprotein profile between Korean and US populations might be due to genetics, environmental factors, or both.

In our study population, the effects of ageing on plasma lipids and lipoprotein-cholesterol fractions significantly differed between males and females. Because females with elevated blood cholesterol tend to be older, they also have a higher chance of developing cardiovascular disease. Furthermore, although plasma levels of TC, LDL-C, HDL-C, and TG are highly heritable,25) environmental factors affect plasma concentrations of these parameters. In previous studies, it has been shown that diet composition, particularly dietary cholesterol and saturated fatty acids, has a significant effect on blood cholesterol.26),27) In females, menopause is an additional determinant of these parameters. The post-menopausal decrease of plasma estrogen levels may play a significant role in reducing the clearance of LDL particles and the subsequent increase in LDL-C levels in postmenopausal women.28) Estrogen replacement treatment has been shown to decrease LDL-C and increase HDL-C levels in dyslipidemic postmenopausal women.29)

The present study has several limitations that need to be discussed. First, the KNHANES was designed to represent the Korean population, but the sample was limited to the non-institutionalized civilian population of Korean. Therefore, people who were admitted to the hospital or nursing homes were not included in this study. Second, LDL-C levels were not directly measured but calculated by the Friedewald's formula. However, this formula has been validated and used extensively to measure LDL-C levels in epidemiological studies.30) Third, we did not control for the effects of prevalent diseases which may affect plasma lipid levels. We were also unable to exclude the participants who were unaware of which medications were prescribed to them. Thus we could not completely eliminate the effects of lipid-lowering medications.

Blood cholesterol levels and lipoprotein-cholesterol fractions present different distributions by age, sex, and menopausal status among the Korean population. Our findings suggest that a subgroup-specific approach is required to develop efficient cardiovascular disease prevention strategies.

Acknowledgments

This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C0715).

Footnotes

The authors have no financial conflicts of interest.

Supplementary Material

The online-only Data Supplement is available with this article at http://dx.doi.org/10.4070/kcj.2015.45.2.141.

kcj-45-141-s001.pdf (34.5KB, pdf)

Supplementary Table 1. Distribution of total cholesterol (mg/dL) by age, sex, menopausal status.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th 90th 95th
Male (n=8284)
 10-14 788 156.9 26.6 117 125 139 156 172 191 204
 15-19 566 151.1 27.3 114 121 133 147 167 184 196
 20-24 327 167.9 29.7 129 134 147 164 187 213 220
 25-29 431 179.1 31.4 129 141 158 177 198 222 234
 30-34 548 188.4 34.3 135 146 166 186 210 230 246
 35-39 765 193.8 33.4 143 153 171 192 213 239 255
 40-44 729 193.9 35.7 139 153 172 192 216 237 249
 45-49 617 196.9 37.9 140 151 174 193 218 242 260
 50-54 659 195.6 33.3 142 154 172 196 216 238 249
 55-59 631 192.1 36.8 134 146 168 190 215 235 255
 60-64 643 187.3 34.4 131 144 164 187 212 231 242
 65-69 554 184.0 32.7 134 144 163 183 203 226 240
 70-74 559 183.6 33.9 128 144 160 181 205 227 242
 75-79 339 179.8 33.9 125 140 159 178 196 224 243
 80+ 128 173.5 33.6 120 129 150 174 194 217 232
Premenopausal female (n=5841)
 10-14 675 163.8 25.3 125 133 147 163 178 198 210
 15-19 524 162.3 26.3 125 132 144 159 178 196 211
 20-24 470 167.2 28.5 124 133 148 164 184 203 216
 25-29 593 174.1 31.0 130 141 153 170 191 214 231
 30-34 790 176.9 32.9 129 139 154 174 195 220 236
 35-39 1039 180.3 32.6 135 142 158 178 200 219 233
 40-44 843 183.1 31.3 138 144 161 181 202 224 240
 45-49 633 194.2 33.2 143 153 173 192 214 235 253
 50-54 274 200.8 33.5 153 160 177 200 223 246 260
Postmenopausal female (n=3405)
 45-49 113 194.6 31.5 143 157 176 190 211 229 254
 50-54 578 208.9 35.9 155 167 186 207 226 255 274
 55-59 590 210.1 36.6 153 165 183 210 234 257 271
 60-64 540 206.8 35.6 148 161 183 207 230 250 266
 65-69 466 205.6 36.2 150 159 182 205 228 252 267
 70-74 542 201.4 36.5 142 156 177 200 223 248 265
 75-79 387 198.4 36.9 144 152 173 197 219 244 264
 80+ 189 197.5 35.7 145 156 170 196 217 243 264
kcj-45-141-s002.pdf (34.4KB, pdf)

Supplementary Table 2. Distribution of total cholesterol (mg/dL) by age, sex, menopausal status not excluding people taking lipid-lowering agents.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th 90th 95th
Male (n=8656)
 10-14 788 156.9 26.6 117 125 139 156 172 191 204
 15-19 566 151.1 27.3 114 121 133 147 167 184 196
 20-24 327 167.9 29.7 129 134 147 164 187 213 220
 25-29 432 179.2 31.6 129 141 158 178 198 222 234
 30-34 550 188.4 34.2 135 146 166 186 210 230 246
 35-39 773 193.7 33.4 142 153 170 192 213 239 255
 40-44 742 193.5 35.7 139 152 171 192 216 237 247
 45-49 640 196.3 38.6 139 150 173 192 218 242 261
 50-54 704 195.1 35.3 141 152 171 194 216 238 250
 55-59 691 190.0 37.6 131 142 166 188 214 235 254
 60-64 714 185.6 34.7 129 141 161 185 211 230 241
 65-69 621 181.4 33.0 128 141 161 181 200 224 238
 70-74 611 182.2 34.9 126 139 159 179 204 225 241
 75-79 360 178.6 33.9 126 139 157 178 196 222 240
 80+ 137 173.2 33.4 120 130 148 173 196 217 232
Premenopausal female (n=5869)
 10-14 675 163.8 25.3 125 133 147 163 178 198 210
 15-19 524 162.3 26.3 125 132 144 159 178 196 211
 20-24 470 167.2 28.5 124 133 148 164 184 203 216
 25-29 593 174.1 31.0 130 141 153 170 191 214 231
 30-34 790 176.9 32.9 129 139 154 174 195 220 236
 35-39 1043 180.3 32.5 136 142 158 178 199 219 233
 40-44 850 182.9 31.4 137 144 161 181 201 225 241
 45-49 645 193.6 33.4 143 152 172 192 213 234 253
 50-54 279 200.7 33.4 153 160 177 200 223 246 260
Postmenopausal female (n=3909)
 45-49 119 193.5 32.3 139 152 175 190 211 230 254
 50-54 617 207.6 36.2 154 164 184 206 226 255 273
 55-59 670 206.8 37.9 145 160 180 206 232 255 271
 60-64 648 202.7 36.5 144 155 177 201 226 248 263
 65-69 578 199.7 36.9 143 154 172 198 223 247 263
 70-74 638 197.9 37.1 138 150 173 197 221 247 264
 75-79 441 195.4 37.5 140 151 168 195 217 242 260
 80+ 198 197.2 35.7 144 156 170 196 216 243 269
kcj-45-141-s003.pdf (34.5KB, pdf)

Supplementary Table 3. Distribution of triglycerides (mg/dL) by age, sex, menopausal status.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th 90th 95th
Male (n=8284)
 10-14 788 77.9 44.3 30 36 47 66 96 138 169
 15-19 566 83.6 44.3 37 42 55 74 98 143 175
 20-24 327 94.9 53.7 39 45 60 84 109 167 207
 25-29 431 130.3 104.3 47 54 74 104 150 218 296
 30-34 548 143.7 100.6 49 57 81 114 182 252 306
 35-39 765 151.6 90.8 54 65 90 130 189 268 316
 40-44 729 161.7 98.4 58 69 92 137 205 287 332
 45-49 617 164.5 115.0 51 68 94 136 200 302 345
 50-54 659 164.7 100.7 58 67 96 138 202 302 355
 55-59 631 159.2 103.9 53 66 96 136 200 272 326
 60-64 643 143.3 84.2 49 59 83 125 180 254 316
 65-69 554 133.1 75.3 45 58 82 118 163 229 276
 70-74 559 128.8 71.8 49 56 77 111 161 225 275
 75-79 339 119.7 69.4 48 55 73 104 144 215 258
 80+ 128 105.7 48.6 51 55 67 99 132 166 209
Premenopausal female (n=5841)
 10-14 675 89.5 48.5 38 44 58 78 107 149 191
 15-19 524 77.4 40.4 34 41 51 68 91 126 156
 20-24 470 75.7 43.5 34 40 51 66 88 118 146
 25-29 593 85.5 57.9 34 39 53 69 100 145 195
 30-34 790 88.5 54.3 34 39 53 72 108 152 194
 35-39 1039 91.7 57.8 36 42 56 75 110 153 194
 40-44 843 94.8 55.0 41 47 59 80 116 159 197
 45-49 633 110.1 69.0 43 49 66 92 129 192 246
 50-54 274 108.8 58.2 46 51 68 93 135 191 221
Postmenopausal female (n=3405)
 45-49 113 113.4 75.0 38 46 62 89 144 198 310
 50-54 578 128.3 77.2 47 56 74 108 156 234 287
 55-59 590 128.6 77.0 46 58 77 110 164 215 268
 60-64 540 135.6 74.9 55 62 81 116 167 241 274
 65-69 466 142.8 75.6 55 65 86 126 180 258 293
 70-74 542 138.6 79.6 53 63 88 123 175 230 263
 75-79 387 134.0 67.6 57 66 87 119 167 220 250
 80+ 189 141.0 67.4 63 72 94 124 170 249 290
kcj-45-141-s004.pdf (34.8KB, pdf)

Supplementary Table 4. Distribution of triglycerides (mg/dL) by age, sex, menopausal status not excluding people taking lipid-lowering agents.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th 90th 95th
Male (n=8656)
 10-14 788 77.9 44.3 30 36 47 66 96 138 169
 15-19 566 83.6 44.3 37 42 55 74 98 143 175
 20-24 327 94.9 53.7 39 45 60 84 109 167 207
 25-29 432 130.8 104.8 47 54 74 104 150 221 297
 30-34 550 144.2 100.7 49 57 81 115 182 253 306
 35-39 773 151.8 90.7 54 65 90 130 190 268 316
 40-44 742 162.6 99.0 58 69 93 137 206 288 335
 45-49 640 165.4 114.6 52 68 94.5 139 201 303 348
 50-54 704 166.6 102.2 58 68 96.5 139 205 302 355
 55-59 691 159.3 103.7 53 66 95 136 200 274 326
 60-64 714 145.8 84.6 50 59 86 128 186 253 316
 65-69 621 135.4 76.2 47 61 83 118 166 240 279
 70-74 611 129.7 71.7 49 57 77 111 162 226 274
 75-79 360 120.2 70.2 47.5 55 73 104 144 215 258
 80+ 137 106.2 49.4 51 55 66 98 132 166 210
Premenopausal female (n=5869)
 10-14 675 89.5 48.5 38 44 58 78 107 149 191
 15-19 524 77.4 40.4 34 41 51 68 91 126 156
 20-24 470 75.7 43.5 34 39.5 51 66 88 118 146
 25-29 593 85.5 57.9 34 39 53 69 100 145 195
 30-34 790 88.5 54.3 34 39 53 72 108 152 194
 35-39 1043 91.8 57.8 36 42 56 75 110 153 194
 40-44 850 95.5 55.7 41 47 60 80 116 160 198
 45-49 645 110.6 68.9 43 49 67 93 129 193 246
 50-54 279 109.2 57.9 46 51 68 94 135 191 221
Postmenopausal female (n=3909)
 45-49 119 117.2 76.1 38 46 64 93 159 229 310
 50-54 617 128.9 76.7 47 56 74 109 157 234 287
 55-59 670 130.2 76.8 46 57.5 78 112 167 221 270
 60-64 648 135.9 74.2 55 63 82 117 167 241 273
 65-69 578 143.3 73.8 56 66 89 126 180 252 293
 70-74 638 137.7 77.4 51 63 86 123 175 230 263
 75-79 441 132.8 67.1 56 66 87 118 164 218 250
 80+ 198 141.9 66.7 63 74 95 125 173 248 290
kcj-45-141-s005.pdf (34.2KB, pdf)

Supplementary Table 5. Distribution of high density lipoprotein-cholesterol (mg/dL) by age, sex, menopausal status.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th 90th 95th
Male (n=8284)
 10-14 788 54.4 10.9 37 41 47 53 62 69 74
 15-19 566 50.3 9.7 36 39 44 49 56 63 68
 20-24 327 53.2 11.6 38 40 45 52 59 69 74
 25-29 431 50.5 11.5 35 38 42 49 57 65 71
 30-34 548 49.4 11.1 34 37 41 48 56 65 71
 35-39 765 49.8 11.5 34 37 42 48 56 65 70
 40-44 729 48.7 10.8 34 36 40 48 55 63 69
 45-49 617 48.5 11.5 33 36 41 47 55 62 69
 50-54 659 49.4 12.2 34 36 41 47 56 65 73
 55-59 631 48.9 12.2 33 35 40 47 55 65 73
 60-64 643 50.0 13.1 34 36 40 48 57 67 76
 65-69 554 48.9 12.9 32 35 40 46.5 56 66 74
 70-74 559 48.9 12.7 32 34 40 47 56 65 72
 75-79 339 48.6 12.5 31 34 40 47 55 65 72
 80+ 128 47.6 12.9 30 32 38 44 57 69 72
Premenopausal female (n=5841)
 10-14 675 54.7 10.5 39 42 47 54 61 68 73
 15-19 524 57.0 10.9 40 44 49.5 56 64 70 75
 20-24 470 59.9 12.9 42 46 51 58 67 77 83
 25-29 593 60.0 13.0 40 43 51 59 68 77 82
 30-34 790 58.6 13.1 39 42 49 58 67 76 81
 35-39 1039 57.4 12.2 39 43 49 57 65 73 79
 40-44 843 55.9 12.7 39 42 47 55 63 71 77
 45-49 633 56.6 11.8 39 43 48 56 64 72 78
 50-54 274 55.9 12.9 37 40 47 54 63 71 80
Postmenopausal female (n=3405)
 45-49 113 55.2 12.7 34 38 46 56 63 70 76
 50-54 578 56.0 13.2 38 40 47 55 63 73 79
 55-59 590 53.4 11.9 37 39 44 52 61 69 73
 60-64 540 52.1 12.3 35 37 43 51 59 69 75
 65-69 466 51.6 11.4 35 38 44 50 59 67 71
 70-74 542 50.7 12.1 34 37 42 49 57 66 73
 75-79 387 50.0 11.3 33 36 42 49 57 64 69
 80+ 189 47.9 10.4 34 36 40 47 54 61 68
kcj-45-141-s006.pdf (34.4KB, pdf)

Supplementary Table 6. Distribution of high density lipoprotein-cholesterol (mg/dL) by age, sex, menopausal status not excluding people taking lipid-lowering agents.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th> 90th 95th
Male (n=8656)
 10-14 788 54.4 10.9 37 41 47 53 62 69 74
 15-19 566 50.3 9.7 36 39 44 49 56 63 68
 20-24 327 53.2 11.6 38 40 45 52 59 69 74
 25-29 432 50.4 11.5 35 38 42 49 57 65 71
 30-34 550 49.4 11.1 34 37 41 48 56 65 71
 35-39 773 49.7 11.4 34 37 42 48 56 65 70
 40-44 742 48.8 10.9 34 36 41 48 55 63 69
 45-49 640 48.4 11.4 33 36 41 47 55 62 69
 50-54 704 49.3 12.1 34 36 41 47 56 65 71
 55-59 691 49.0 12.2 33 36 41 47 55 65 73
 60-64 714 49.8 12.9 34 35 41 48 56 67 75
 65-69 621 48.8 12.7 32 35 40 47 56 66 72
 70-74 611 49.0 12.7 32 34 40 46 56 66 72
 75-79 360 48.5 12.5 31 34 40 47 55 65 72
 80+ 137 48.2 13.0 30 33 38 46 57 69 72
Premenopausal female (n=5869)
 10-14 675 54.7 10.5 39 42 47 54 61 68 73
 15-19 524 57.0 10.9 40 44 50 56 64 70 75
 20-24 470 59.9 12.9 42 46 51 58 67 77 83
 25-29 593 60.0 13.0 40 43 51 59 68 77 82
 30-34 790 58.6 13.1 39 42 49 58 67 76 81
 35-39 1043 57.4 12.2 39 43 49 57 65 73 79
 40-44 850 55.8 12.7 38 41 46 55 63 71 77
 45-49 645 56.5 11.8 39 43 48 56 64 72 77
 50-54 279 56.0 12.9 37 40 47 54 63 72 80
Postmenopausal female (n=3909)
 45-49 119 54.5 12.8 34 38 45 56 63 70 76
 50-54 617 56.1 13.2 38 41 47 55 63 73 79
 55-59 670 53.3 12.0 36 39 44 52 61 69 73
 60-64 648 52.4 12.4 35 37 43 51 60 69 75
 65-69 578 51.6 11.3 35 38 43 50 59 67 71
 70-74 638 51.1 12.5 33 37 43 49 58 67 73
 75-79 441 50.1 11.5 33 36 42 50 57 64 70
 80+ 198 48.0 10.2 34 36 40 47 54 61 68
kcj-45-141-s007.pdf (34.5KB, pdf)

Supplementary Table 7. Distribution of low density lipoprotein-cholesterol (mg/dL) by age, sex, menopausal status.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th 90th 95th
Male (n=8284)
 10-14 788 86.9 22.4 53 61 72 85 100 116 126
 15-19 566 84.1 24.0 50 57 69 82 98 113 124
 20-24 327 95.7 26.2 60 65 76 91 111 131 145
 25-29 431 103.6 28.0 60 67 86 103 120 140 153
 30-34 548 111.2 31.4 67 74 91 110 128 147 163
 35-39 765 114.3 30.2 68 78 94 113 133 154 168
 40-44 729 113.4 32.0 64 75 92 114 132 154 166
 45-49 617 116.4 34.3 63 75 94 116 137 156 174
 50-54 659 114.1 31.6 65 77 91 114 133 155 168
 55-59 631 111.9 33.8 60 71 91 109 132 155 170
 60-64 643 108.9 32.4 55 68 88 107 130 153 164
 65-69 554 108.7 30.6 56 71 89 109 127 147 159
 70-74 559 109.0 31.1 59 71 87 108 129 146 162
 75-79 339 107.3 31.1 57 67 88 107 127 147 160
 80+ 128 104.7 29.2 60 66 83 104 124 142 159
Premenopausal female (n=5841)
 10-14 675 91.2 21.9 58 64 77 89 105 121 130
 15-19 524 89.9 22.4 58 63 74 88 102 119 130
 20-24 470 92.1 24.2 57 64 76 89 106 123 134
 25-29 593 97.1 25.9 61 69 81 93 110 131 144
 30-34 790 100.7 27.2 63 68 81 97 117 135 149
 35-39 1039 104.6 28.2 65 73 85 102 121 141 154
 40-44 843 108.3 26.6 68 75 89 107 124 144 157
 45-49 633 115.8 29.7 72 80 95 115 132 151 165
 50-54 274 123.1 28.3 78 89 103 123 140 160 175
Postmenopausal female (n=3405)
 45-49 113 116.7 29.8 68 86 97 115 134 151 176
 50-54 578 127.4 31.6 78 90 106 126 144 168 183
 55-59 590 131.0 33.0 78 89 109 130 154 173 188
 60-64 540 127.6 31.9 75 86 105 127 148 168 181
 65-69 466 125.5 32.4 76 83 104 125 145 168 180
 70-74 542 123.1 32.4 70 82 101 123 146 165 177
 75-79 387 121.7 33.2 72 81 98 119 143 164 178
 80+ 189 121.4 32.7 71 81 98 120 138 166 185
kcj-45-141-s008.pdf (34.7KB, pdf)

Supplementary Table 8. Distribution of low density lipoprotein-cholesterol (mg/dL) by age, sex, menopausal status not excluding people taking lipid-lowering agents.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th 90th 95th
Male (n=8656)
 10-14 788 86.9 22.4 53 61 72 85 100 116 126
 15-19 566 84.1 24.0 50 57 69 82 98 113 124
 20-24 327 95.7 26.2 60 65 76 91 111 131 145
 25-29 432 103.7 28.0 60 67 86 103 120 140 153
 30-34 550 111.2 31.3 67 74 91 110 128 147 163
 35-39 773 114.1 30.3 68 78 94 113 133 154 168
 40-44 742 112.8 32.1 64 73 90 113 132 153 166
 45-49 640 115.8 35.0 61 74 92 115 136 156 175
 50-54 704 113.3 32.9 65 75 90 112 133 155 168
 55-59 691 109.7 34.2 58 69 88 108 130 154 169
 60-64 714 106.9 32.9 52 63 84 105 129 151 162
 65-69 621 105.8 31.2 54 67 85 106 125 146 157
 70-74 611 107.3 31.8 57 69 85 107 127 146 162
 75-79 360 106.2 31.3 57 66 83 105 126 147 157
 80+ 137 103.8 29.4 59 65 80 103 123 142 159
Premenopausal female (n=5869)
 10-14 675 91.2 21.9 58 64 77 89 105 121 130
 15-19 524 89.9 22.4 58 63 74 88 102 119 130
 20-24 470 92.1 24.2 57 64 76 89 106 123 134
 25-29 593 97.1 25.9 61 69 81 93 110 131 144
 30-34 790 100.7 27.2 63 68 81 97 117 135 149
 35-39 1043 104.6 28.2 65 73 85 102 121 140 153
 40-44 850 108.1 26.7 68 75 89 107 124 144 157
 45-49 645 115.2 30.0 71 79 95 114 132 150 164
 50-54 279 122.9 28.6 78 89 102 122 140 161 175
Postmenopausal female (n=3909)
 45-49 119 115.6 30.7 61 79 95 114 134 155 176
 50-54 617 125.9 32.2 75 86 105 124 144 167 183
 55-59 670 127.5 34.7 74 82 104 127 152 172 187
 60-64 648 123.1 33.0 72 81 99 122 146 165 176
 65-69 578 119.4 33.9 67 76 94 118 142 163 177
 70-74 638 119.3 33.2 67 76 97 118 142 163 177
 75-79 441 118.8 33.5 70 78 94 117 140 160 176
 80+ 198 120.8 32.9 71 76 98 120 137 166 188
kcj-45-141-s009.pdf (34.4KB, pdf)

Supplementary Table 9. Distribution of total cholesterol/high density lipoprotein-cholesterol ratio by age, sex, menopausal status.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th> 90th 95th
Male (n=8284)
 10-14 788 2.97 0.65 2.10 2.23 2.50 2.85 3.33 3.89 4.19
 15-19 566 3.09 0.72 2.17 2.28 2.62 2.98 3.43 3.97 4.44
 20-24 327 3.28 0.87 2.14 2.32 2.68 3.12 3.74 4.36 4.98
 25-29 431 3.71 1.01 2.30 2.52 2.98 3.57 4.31 5.08 5.63
 30-34 548 3.99 1.10 2.41 2.67 3.20 3.84 4.65 5.50 5.88
 35-39 765 4.08 1.10 2.48 2.72 3.26 4.02 4.76 5.52 6.06
 40-44 729 4.16 1.13 2.56 2.79 3.35 4.05 4.87 5.65 6.10
 45-49 617 4.24 1.12 2.61 2.91 3.45 4.14 4.92 5.74 6.13
 50-54 659 4.16 1.09 2.59 2.87 3.36 4.05 4.79 5.62 6.13
 55-59 631 4.12 1.13 2.44 2.75 3.30 4.00 4.78 5.56 6.08
 60-64 643 3.94 1.06 2.43 2.65 3.12 3.84 4.66 5.33 5.72
 65-69 554 3.96 1.06 2.40 2.60 3.18 3.89 4.72 5.37 5.74
 70-74 559 3.96 1.13 2.45 2.65 3.08 3.84 4.64 5.43 5.96
 75-79 339 3.90 1.09 2.40 2.61 3.05 3.74 4.58 5.30 5.97
 80+ 128 3.85 1.13 2.35 2.54 3.05 3.71 4.25 5.47 6.48
Premenopausal female (n=5841)
 10-14 675 3.08 0.66 2.26 2.41 2.61 2.97 3.40 3.91 4.35
 15-19 524 2.93 0.68 2.09 2.21 2.49 2.81 3.23 3.77 4.19
 20-24 470 2.88 0.67 2.07 2.21 2.43 2.78 3.17 3.69 4.26
 25-29 593 3.01 0.78 2.08 2.24 2.52 2.84 3.34 4.00 4.53
 30-34 790 3.14 0.78 2.16 2.28 2.56 2.98 3.56 4.15 4.70
 35-39 1039 3.25 0.82 2.27 2.41 2.66 3.08 3.66 4.35 4.84
 40-44 843 3.40 0.80 2.32 2.47 2.81 3.27 3.88 4.50 4.85
 45-49 633 3.56 0.88 2.40 2.57 2.91 3.41 4.07 4.71 5.23
 50-54 274 3.72 0.85 2.51 2.71 3.09 3.62 4.26 4.93 5.31
Postmenopausal female (n=3405)
 45-49 113 3.69 0.91 2.39 2.56 3.02 3.61 4.23 4.87 5.49
 50-54 578 3.90 1.03 2.56 2.74 3.11 3.70 4.46 5.36 5.91
 55-59 590 4.08 0.99 2.59 2.89 3.42 3.97 4.66 5.32 5.85
 60-64 540 4.14 1.02 2.63 2.86 3.32 4.08 4.85 5.57 5.96
 65-69 466 4.15 1.04 2.61 2.90 3.38 4.03 4.76 5.63 6.07
 70-74 542 4.15 1.08 2.59 2.80 3.33 4.06 4.88 5.53 6.03
 75-79 387 4.14 1.09 2.68 2.91 3.39 4.02 4.73 5.59 6.03
 80+ 189 4.27 1.03 2.84 3.03 3.50 4.16 4.90 5.60 6.03
kcj-45-141-s010.pdf (34.5KB, pdf)

Supplementary Table 10. Distribution of total cholesterol/high density lipoprotein-cholesterol ratio by age, sex, menopausal status not excluding people taking lipid-lowering agents.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th 90th 95th
Male (n=8656)
 10-14 788 3.0 0.6 2.10 2.23 2.50 2.85 3.33 3.89 4.19
 15-19 566 3.1 0.7 2.17 2.28 2.62 2.98 3.43 3.97 4.44
 20-24 327 3.3 0.9 2.14 2.32 2.68 3.12 3.74 4.36 4.98
 25-29 432 3.7 1.0 2.30 2.52 2.98 3.57 4.32 5.12 5.64
 30-34 550 4.0 1.1 2.41 2.67 3.20 3.84 4.65 5.48 5.88
 35-39 773 4.1 1.1 2.48 2.72 3.27 4.02 4.76 5.51 6.06
 40-44 742 4.1 1.1 2.56 2.80 3.33 4.04 4.86 5.62 6.10
 45-49 640 4.2 1.1 2.61 2.90 3.45 4.13 4.89 5.73 6.13
 50-54 704 4.2 1.2 2.57 2.87 3.34 4.04 4.77 5.62 6.13
 55-59 691 4.1 1.1 2.40 2.71 3.25 3.94 4.74 5.51 6.06
 60-64 714 3.9 1.1 2.42 2.63 3.07 3.82 4.66 5.37 5.72
 65-69 621 3.9 1.1 2.37 2.58 3.14 3.81 4.67 5.31 5.72
 70-74 611 3.9 1.1 2.40 2.62 3.06 3.81 4.60 5.36 5.93
 75-79 360 3.9 1.1 2.40 2.58 3.02 3.72 4.58 5.32 5.99
 80+ 137 3.8 1.1 2.32 2.52 3.03 3.62 4.23 5.32 6.48
Premenopausal female (n=5869)
 10-14 675 3.1 0.7 2.26 2.41 2.61 2.97 3.40 3.91 4.35
 15-19 524 2.9 0.7 2.09 2.21 2.49 2.81 3.23 3.77 4.19
 20-24 470 2.9 0.7 2.07 2.21 2.43 2.78 3.17 3.69 4.26
 25-29 593 3.0 0.8 2.08 2.24 2.52 2.84 3.34 4.00 4.53
 30-34 790 3.1 0.8 2.16 2.28 2.56 2.98 3.56 4.15 4.70
 35-39 1043 3.3 0.8 2.27 2.41 2.66 3.08 3.66 4.35 4.84
 40-44 850 3.4 0.8 2.31 2.47 2.81 3.27 3.88 4.51 4.87
 45-49 645 3.6 0.9 2.39 2.57 2.91 3.40 4.07 4.71 5.16
 50-54 279 3.7 0.9 2.50 2.69 3.08 3.61 4.26 4.95 5.31
Postmenopausal female (n=3909)
 45-49 119 3.7 1.0 2.39 2.56 3.02 3.61 4.23 5.04 5.56
 50-54 617 3.9 1.0 2.51 2.70 3.08 3.66 4.44 5.36 5.90
 55-59 670 4.0 1.0 2.57 2.82 3.33 3.91 4.60 5.29 5.83
 60-64 648 4.0 1.0 2.55 2.79 3.24 3.95 4.72 5.44 5.85
 65-69 578 4.0 1.0 2.52 2.79 3.25 3.89 4.66 5.54 5.90
 70-74 638 4.1 1.1 2.49 2.74 3.22 3.97 4.78 5.50 5.98
 75-79 441 4.1 1.1 2.64 2.86 3.30 3.91 4.63 5.46 5.91
 80+ 198 4.3 1.0 2.84 3.06 3.48 4.14 4.88 5.54 6.03
kcj-45-141-s011.pdf (34.4KB, pdf)

Supplementary Table 11. Distribution of low density lipoprotein-cholesterol/high density lipoprotein-cholesterol ratio by age, sex, menopausal status.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th 90th 95th
Male (n=8284)
 10-14 788 1.66 0.52 0.91 1.04 1.29 1.59 1.97 2.38 2.62
 15-19 566 1.74 0.62 0.92 1.05 1.34 1.65 2.02 2.50 2.86
 20-24 327 1.89 0.70 0.99 1.12 1.40 1.77 2.28 2.75 3.14
 25-29 431 2.14 0.78 1.01 1.22 1.59 2.05 2.59 3.19 3.61
 30-34 553 2.34 0.86 1.03 1.37 1.76 2.23 2.82 3.33 3.81
 35-39 786 2.39 0.87 1.11 1.38 1.80 2.31 2.94 3.46 3.93
 40-44 740 2.41 0.88 1.14 1.38 1.81 2.34 2.97 3.52 3.95
 45-49 626 2.48 0.90 1.13 1.43 1.84 2.42 3.02 3.68 4.00
 50-54 673 2.39 0.89 1.07 1.42 1.79 2.33 2.88 3.59 4.07
 55-59 637 2.40 0.92 1.05 1.29 1.76 2.32 2.91 3.57 3.94
 60-64 648 2.29 0.86 1.05 1.29 1.63 2.22 2.82 3.48 3.79
 65-69 558 2.34 0.87 0.95 1.28 1.74 2.26 2.89 3.49 3.81
 70-74 563 2.37 0.92 1.10 1.30 1.70 2.27 2.91 3.62 3.97
 75-79 341 2.34 0.87 1.08 1.27 1.71 2.27 2.89 3.48 3.88
 80+ 129 2.33 0.93 1.16 1.22 1.68 2.26 2.73 3.58 4.18
Premenopausal female (n=5841)
 10-14 675 1.72 0.52 1.01 1.15 1.37 1.64 2.00 2.39 2.68
 15-19 524 1.64 0.54 0.92 1.02 1.28 1.54 1.92 2.34 2.63
 20-24 470 1.61 0.56 0.88 1.00 1.22 1.54 1.88 2.29 2.79
 25-29 593 1.70 0.63 0.92 1.05 1.29 1.60 2.02 2.44 2.81
 30-34 790 1.80 0.63 0.97 1.10 1.35 1.72 2.17 2.59 3.04
 35-39 1039 1.91 0.67 1.05 1.19 1.44 1.80 2.23 2.81 3.12
 40-44 843 2.03 0.65 1.12 1.27 1.56 1.95 2.40 2.89 3.23
 45-49 633 2.13 0.71 1.13 1.33 1.63 2.05 2.55 3.05 3.44
 50-54 274 2.29 0.67 1.32 1.47 1.79 2.21 2.78 3.21 3.42
Postmenopausal female (n=3405)
 45-49 113 2.22 0.70 1.14 1.31 1.74 2.23 2.64 3.16 3.43
 50-54 578 2.39 0.80 1.32 1.47 1.80 2.29 2.85 3.44 3.76
 55-59 590 2.55 0.79 1.36 1.60 2.02 2.49 3.01 3.55 3.97
 60-64 540 2.57 0.81 1.31 1.54 1.94 2.55 3.10 3.68 3.99
 65-69 466 2.53 0.81 1.36 1.53 1.99 2.45 3.00 3.64 4.02
 70-74 542 2.55 0.86 1.29 1.50 1.90 2.47 3.09 3.67 4.14
 75-79 387 2.54 0.85 1.32 1.61 1.95 2.48 2.98 3.73 4.01
 80+ 189 2.63 0.84 1.40 1.68 2.04 2.50 3.21 3.68 4.14
kcj-45-141-s012.pdf (34.4KB, pdf)

Supplementary Table 12. Distribution of low density lipoprotein-cholesterol/high density lipoprotein-cholesterol ratio by age, sex, menopausal status not excluding people taking lipid-lowering agents.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th 90th 95th
Male (n=8656)
 10-14 788 1.7 0.5 0.91 1.04 1.29 1.59 1.97 2.38 2.62
 15-19 566 1.7 0.6 0.92 1.05 1.34 1.65 2.02 2.50 2.86
 20-24 327 1.9 0.7 0.99 1.12 1.40 1.77 2.28 2.75 3.14
 25-29 432 2.2 0.8 1.04 1.23 1.61 2.09 2.62 3.21 3.62
 30-34 550 2.4 0.9 1.11 1.41 1.80 2.27 2.84 3.33 3.85
 35-39 773 2.4 0.9 1.17 1.40 1.82 2.34 2.95 3.51 3.96
 40-44 742 2.4 0.9 1.19 1.40 1.83 2.35 2.95 3.50 3.91
 45-49 640 2.5 0.9 1.21 1.47 1.85 2.41 3.01 3.68 4.04
 50-54 704 2.4 0.9 1.18 1.45 1.83 2.33 2.92 3.59 4.07
 55-59 691 2.4 0.9 1.08 1.29 1.73 2.28 2.87 3.52 3.92
 60-64 714 2.3 0.9 0.98 1.29 1.60 2.19 2.81 3.44 3.79
 65-69 621 2.3 0.9 0.97 1.26 1.70 2.22 2.86 3.44 3.78
 70-74 611 2.3 0.9 1.08 1.28 1.65 2.22 2.89 3.58 3.93
 75-79 360 2.3 0.9 1.08 1.25 1.67 2.23 2.88 3.50 3.93
 80+ 137 2.3 0.9 1.14 1.22 1.65 2.19 2.73 3.55 4.18
Premenopausal female (n=5869)
 10-14 675 1.7 0.5 1.01 1.15 1.37 1.64 2.00 2.39 2.68
 15-19 524 1.6 0.5 0.92 1.02 1.28 1.54 1.92 2.34 2.63
 20-24 470 1.6 0.6 0.88 1.00 1.22 1.54 1.88 2.29 2.79
 25-29 593 1.7 0.6 0.92 1.05 1.29 1.60 2.02 2.44 2.81
 30-34 790 1.8 0.6 0.97 1.10 1.35 1.72 2.17 2.59 3.04
 35-39 1043 1.9 0.7 1.05 1.19 1.44 1.80 2.23 2.80 3.12
 40-44 850 2.0 0.7 1.12 1.26 1.56 1.95 2.40 2.89 3.25
 45-49 645 2.1 0.7 1.11 1.33 1.63 2.03 2.54 3.05 3.43
 50-54 279 2.3 0.7 1.28 1.41 1.79 2.21 2.78 3.23 3.43
Postmenopausal female (n=3909)
 45-49 119 2.2 0.8 1.14 1.31 1.74 2.20 2.64 3.23 3.46
 50-54 617 2.4 0.8 1.26 1.44 1.77 2.26 2.83 3.44 3.76
 55-59 670 2.5 0.8 1.26 1.46 1.91 2.43 2.95 3.53 3.90
 60-64 648 2.5 0.8 1.24 1.41 1.84 2.42 3.00 3.60 3.93
 65-69 578 2.4 0.8 1.21 1.42 1.83 2.30 2.91 3.48 3.97
 70-74 638 2.5 0.9 1.20 1.40 1.80 2.40 2.99 3.60 4.09
 75-79 441 2.5 0.9 1.27 1.51 1.86 2.42 2.92 3.53 3.96
 80+ 198 2.6 0.8 1.40 1.66 2.02 2.47 3.20 3.67 4.14
kcj-45-141-s013.pdf (34.4KB, pdf)

Supplementary Table 13. Distribution of triglycerides/high density lipoprotein-cholesterol ratio by age, sex, menopausal status.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th 90th 95th
Male (n=8284)
 10-14 788 1.55 1.12 0.50 0.60 0.85 1.20 1.85 3.14 3.84
 15-19 566 1.76 1.11 0.68 0.79 1.05 1.46 2.12 3.09 3.84
 20-24 327 1.96 1.42 0.63 0.76 1.03 1.58 2.30 3.64 4.88
 25-29 431 2.88 2.90 0.73 0.94 1.36 2.06 3.42 5.35 7.07
 30-34 553 3.33 2.95 0.86 1.05 1.51 2.35 4.25 6.33 8.66
 35-39 786 3.65 3.13 0.90 1.19 1.71 2.75 4.41 7.17 9.22
 40-44 740 3.81 2.99 1.02 1.26 1.79 2.95 4.88 7.56 9.57
 45-49 626 3.90 3.36 0.86 1.22 1.88 2.98 4.71 7.71 9.72
 50-54 673 3.95 3.33 0.96 1.22 1.84 3.06 4.79 7.66 10.45
 55-59 637 3.71 3.07 0.91 1.16 1.88 2.89 4.63 6.53 8.70
 60-64 648 3.27 2.41 0.78 1.02 1.53 2.54 4.27 6.51 8.20
 65-69 558 3.21 3.03 0.76 1.02 1.57 2.59 3.86 5.86 7.39
 70-74 563 2.99 2.10 0.81 1.00 1.45 2.45 3.81 5.91 7.33
 75-79 341 2.88 2.48 0.78 0.93 1.43 2.27 3.30 5.28 7.65
 80+ 129 2.70 2.64 0.82 0.93 1.32 2.07 3.00 5.36 5.96
Premenopausal female (n=5841)
 10-14 675 1.78 1.31 0.62 0.72 1.00 1.40 2.14 3.14 4.13
 15-19 524 1.47 1.04 0.55 0.63 0.86 1.20 1.70 2.38 3.26
 20-24 470 1.37 1.05 0.51 0.61 0.82 1.14 1.56 2.32 2.72
 25-29 593 1.56 1.29 0.48 0.58 0.84 1.16 1.75 3.05 4.14
 30-34 790 1.67 1.34 0.51 0.62 0.85 1.28 2.00 3.05 3.90
 35-39 1039 1.75 1.42 0.55 0.67 0.92 1.35 2.07 3.15 4.16
 40-44 843 1.86 1.36 0.62 0.75 0.98 1.48 2.27 3.36 4.24
 45-49 633 2.12 1.58 0.64 0.77 1.10 1.67 2.60 4.13 5.39
 50-54 274 2.15 1.48 0.69 0.83 1.10 1.78 2.62 3.85 5.48
Postmenopausal female (n=3405)
 45-49 113 2.35 2.12 0.65 0.83 1.11 1.51 2.88 5.35 7.65
 50-54 578 2.57 2.02 0.71 0.88 1.28 1.91 3.18 5.16 6.67
 55-59 590 2.68 2.04 0.73 0.92 1.35 2.12 3.43 5.06 6.26
 60-64 540 2.89 2.02 0.82 1.02 1.43 2.36 3.67 5.55 7.01
 65-69 466 3.07 2.10 0.88 1.03 1.53 2.45 4.06 5.98 7.00
 70-74 542 3.02 2.18 0.86 1.11 1.64 2.45 3.95 5.83 6.88
 75-79 387 2.98 2.06 0.93 1.05 1.61 2.39 3.70 5.44 7.12
 80+ 189 3.20 1.97 1.02 1.30 1.83 2.63 4.03 5.70 7.26
kcj-45-141-s014.pdf (34.5KB, pdf)

Supplementary Table 14. Distribution of triglycerides/high density lipoprotein-cholesterol ratio by age, sex, menopausal status not excluding people taking lipid-lowering agents.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th 90th 95th
Male (n=8656)
 10-14 788 1.6 1.1 0.50 0.60 0.85 1.20 1.85 3.14 3.84
 15-19 566 1.8 1.1 0.68 0.79 1.05 1.46 2.12 3.09 3.84
 20-24 327 2.0 1.4 0.63 0.76 1.03 1.58 2.30 3.64 4.88
 25-29 432 2.9 2.9 0.73 0.94 1.37 2.06 3.42 5.38 7.22
 30-34 550 3.2 2.8 0.86 1.05 1.49 2.33 4.21 6.26 8.43
 35-39 773 3.4 2.5 0.90 1.18 1.68 2.71 4.20 6.36 7.92
 40-44 742 3.7 2.8 1.02 1.27 1.79 2.91 4.81 7.09 8.68
 45-49 640 3.8 3.1 0.87 1.23 1.89 2.97 4.63 7.42 9.04
 50-54 704 3.8 2.8 0.96 1.22 1.85 3.05 4.71 7.24 9.00
 55-59 691 3.6 2.8 0.92 1.17 1.85 2.85 4.56 6.44 8.21
 60-64 714 3.3 2.4 0.80 1.03 1.59 2.57 4.27 6.45 8.15
 65-69 621 3.1 2.2 0.79 1.04 1.58 2.58 3.96 5.80 7.17
 70-74 611 3.0 2.0 0.81 1.02 1.47 2.43 3.78 5.65 7.11
 75-79 360 2.8 2.3 0.76 0.91 1.42 2.23 3.30 5.30 7.46
 80+ 137 2.5 1.7 0.82 0.93 1.29 2.02 2.98 5.16 5.96
Premenopausal female (n=5869)
 10-14 675 1.8 1.3 0.62 0.72 1.00 1.40 2.14 3.14 4.13
 15-19 524 1.5 1.0 0.55 0.63 0.86 1.20 1.70 2.38 3.26
 20-24 470 1.4 1.1 0.51 0.61 0.82 1.14 1.56 2.32 2.72
 25-29 593 1.6 1.3 0.48 0.58 0.84 1.16 1.75 3.05 4.14
 30-34 790 1.7 1.3 0.51 0.62 0.85 1.28 2.00 3.05 3.90
 35-39 1043 1.8 1.4 0.56 0.67 0.92 1.35 2.08 3.15 4.16
 40-44 850 1.9 1.4 0.62 0.76 0.99 1.49 2.28 3.46 4.36
 45-49 645 2.1 1.6 0.65 0.77 1.11 1.68 2.61 4.15 5.39
 50-54 279 2.2 1.5 0.69 0.83 1.10 1.78 2.67 3.90 5.48
Postmenopausal female (n=3909)
 45-49 119 2.5 2.2 0.65 0.83 1.11 1.51 3.14 5.79 7.65
 50-54 617 2.6 2.0 0.71 0.88 1.29 1.91 3.18 5.16 6.66
 55-59 670 2.7 2.0 0.73 0.92 1.35 2.16 3.44 5.08 6.39
 60-64 648 2.9 2.0 0.82 1.02 1.45 2.32 3.69 5.57 6.83
 65-69 578 3.1 2.0 0.89 1.07 1.57 2.50 4.02 5.94 7.02
 70-74 638 3.0 2.1 0.82 1.05 1.62 2.43 3.89 5.66 6.87
 75-79 441 2.9 2.0 0.93 1.10 1.61 2.38 3.63 5.32 7.12
 80+ 198 3.2 1.9 1.02 1.31 1.87 2.70 4.03 5.70 7.26
kcj-45-141-s015.pdf (34.6KB, pdf)

Supplementary Table 15. Distribution of non-high density lipoprotein-cholesterol (mg/dL) by age, sex, menopausal status.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th 90th 95th
Male (n=8284)
 10-14 788 102.5 24.8 65 74 85 100 118 134 144
 15-19 566 100.9 26.5 65 70 83 98 115 133 145
 20-24 327 114.7 29.8 74 81 92 109 133 153 170
 25-29 431 128.6 32.6 82 89 105 126 149 171 186
 30-34 553 139.4 35.7 84 95 116 139 163 182 195
 35-39 786 144.9 35.0 91 103 120 144 167 191 210
 40-44 740 146.1 37.0 90 102 122 144 169 191 203
 45-49 626 149.2 38.3 95 103 124 146 172 195 214
 50-54 673 147.1 34.2 96 106 124 146 168 191 205
 55-59 637 143.8 37.0 88 97 118 142 166 188 206
 60-64 648 137.5 33.8 83 94 113 136 160 181 196
 65-69 558 135.4 33.5 82 92 114 134 157 178 189
 70-74 563 135.2 35.2 82 95 110 133 156 179 195
 75-79 341 131.4 33.6 80 91 109 130 152 176 192
 80+ 129 126.1 32.5 77 84 102 124 142 171 185
Premenopausal female (n=5841)
 10-14 675 109.1 23.6 73 81 93 106 123 140 150
 15-19 524 105.4 25.3 69 76 88 102 119 137 153
 20-24 470 107.3 26.7 71 77 89 104 123 142 155
 25-29 593 114.1 29.8 75 83 95 110 129 151 171
 30-34 790 118.4 30.6 76 83 96 114 136 158 175
 35-39 1039 122.9 31.6 80 87 100 119 140 163 180
 40-44 843 127.2 29.6 83 92 107 125 144 167 180
 45-49 633 137.6 32.9 89 96 115 136 156 179 195
 50-54 274 144.8 31.4 97 104 121 144 166 184 200
Postmenopausal female (n=3405)
 45-49 113 139.4 30.8 96 104 116 140 158 171 194
 50-54 578 152.9 35.5 102 111 128 150 172 198 218
 55-59 590 156.7 35.3 100 112 132 156 180 203 217
 60-64 540 154.7 34.4 98 110 131 154 179 198 211
 65-69 466 154.0 35.6 97 109 128 154 177 200 210
 70-74 542 150.7 36.0 93 103 127 150 174 197 208
 75-79 387 148.4 36.0 94 102 125 148 167 191 209
 80+ 189 149.6 34.6 100 109 125 147 167 195 215
kcj-45-141-s016.pdf (34.8KB, pdf)

Supplementary Table 16. Distribution of non-high density lipoprotein-cholesterol (mg/dL) by age, sex, menopausal status not excluding people taking lipid-lowering agents.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th 90th 95th
Male (n=8656)
 10-14 788 102.5 24.8 65 74 85 100 118 134 144
 15-19 566 100.9 26.5 65 70 83 98 115 133 145
 20-24 327 114.7 29.8 74 81 92 109 133 153 170
 25-29 432 128.8 32.9 82 89 105 126 150 172 187
 30-34 550 139.0 35.3 84 95 116 139 163 182 194
 35-39 773 144.0 34.6 90 102 119 143 166 189 207
 40-44 742 144.8 36.3 90 102 122 143 167 190 202
 45-49 640 147.9 38.5 93 102 124 145 171 192 212
 50-54 704 145.9 35.5 94 103 122 144 167 191 205
 55-59 691 141.0 37.2 85 94 115 140 164 185 204
 60-64 714 135.8 34.3 81 89 110 134 159 181 193
 65-69 621 132.6 32.9 80 88 112 131 154 175 188
 70-74 611 133.2 34.5 79 93 108 131 155 178 194
 75-79 360 130.1 33.9 78 90 107 128 151 176 192
 80+ 137 125.0 32.5 77 82 101 124 142 168 185
Premenopausal female (n=5869)
 10-14 675 109.1 23.6 73 81 93 106 123 140 150
 15-19 524 105.4 25.3 69 76 88 102 119 137 153
 20-24 470 107.3 26.7 71 77 89 104 123 142 155
 25-29 593 114.1 29.8 75 83 95 110 129 151 171
 30-34 790 118.4 30.6 76 83 96 114 136 158 175
 35-39 1043 122.9 31.6 80 87 100 119 140 162 179
 40-44 850 127.1 29.8 82 92 106 125 143 168 181
 45-49 645 137.1 32.9 89 95 114 135 156 179 193
 50-54 279 144.7 31.5 97 103 120 144 166 186 200
Postmenopausal female (n=3909)
 45-49 119 139.0 31.7 93 100 114 139 158 175 194
 50-54 617 151.5 36.0 98 109 126 148 171 198 218
 55-59 670 153.5 36.7 96 106 127 152 177 203 217
 60-64 648 150.3 35.3 91 104 125 149 174 195 209
 65-69 578 148.1 36.4 90 102 122 145 172 197 208
 70-74 638 146.8 36.7 89 100 122 146 171 196 207
 75-79 441 145.3 36.3 91 99 120 144 165 189 206
 80+ 198 149.2 34.6 98 109 124 147 167 195 217

References

  • 1.Farzadfar F, Finucane MM, Danaei G, et al. National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3·0 million participants. Lancet. 2011;377:578–586. doi: 10.1016/S0140-6736(10)62038-7. [DOI] [PubMed] [Google Scholar]
  • 2.Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT) JAMA. 1986;256:2823–2828. [PubMed] [Google Scholar]
  • 3.Natarajan S, Glick H, Criqui M, Horowitz D, Lipsitz SR, Kinosian B. Cholesterol measures to identify and treat individuals at risk for coronary heart disease. Am J Prev Med. 2003;25:50–57. doi: 10.1016/s0749-3797(03)00092-8. [DOI] [PubMed] [Google Scholar]
  • 4.Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989;79:8–15. doi: 10.1161/01.cir.79.1.8. [DOI] [PubMed] [Google Scholar]
  • 5.Kinosian B, Glick H, Preiss L, Puder KL. Cholesterol and coronary heart disease: predicting risks in men by changes in levels and ratios. J Investig Med. 1995;43:443–450. [PubMed] [Google Scholar]
  • 6.Kastelein JJ, van der Steeg WA, Holme I, et al. Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment. Circulation. 2008;117:3002–3009. doi: 10.1161/CIRCULATIONAHA.107.713438. [DOI] [PubMed] [Google Scholar]
  • 7.Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation. 1991;83:356–362. doi: 10.1161/01.cir.83.1.356. [DOI] [PubMed] [Google Scholar]
  • 8.Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996;3:213–219. [PubMed] [Google Scholar]
  • 9.Assmann G, Schulte H, Funke H, von Eckardstein A. The emergence of triglycerides as a significant independent risk factor in coronary artery disease. Eur Heart J. 1998;19(Suppl M):M8–M14. [PubMed] [Google Scholar]
  • 10.Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110:1245–1250. doi: 10.1161/01.CIR.0000140677.20606.0E. [DOI] [PubMed] [Google Scholar]
  • 11.Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med. 2005;165:2644–2650. doi: 10.1001/archinte.165.22.2644. [DOI] [PubMed] [Google Scholar]
  • 12.Gaziano JM, Hennekens CH, O'Donnell CJ, Breslow JL, Buring JE. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation. 1997;96:2520–2525. doi: 10.1161/01.cir.96.8.2520. [DOI] [PubMed] [Google Scholar]
  • 13.Packard CJ, Saito Y. Non-HDL cholesterol as a measure of atherosclerotic risk. J Atheroscler Thromb. 2004;11:6–14. doi: 10.5551/jat.11.6. [DOI] [PubMed] [Google Scholar]
  • 14.Lee MH, Kim HC, Ahn SV, et al. Prevalence of Dyslipidemia among Korean Adults: Korea National Health and Nutrition Survey 1998-2005. Diabetes Metab J. 2012;36:43–55. doi: 10.4093/dmj.2012.36.1.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Roh E, Ko SH, Kwon HS, et al. Prevalence and Management of Dyslipidemia in Korea: Korea National Health and Nutrition Examination Survey during 1998 to 2010. Diabetes Metab J. 2013;37:433–449. doi: 10.4093/dmj.2013.37.6.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Nam GE, Han K, Park YG, et al. Trends in lipid profiles among South Korean adults: 2005, 2008 and 2010 Korea National Health and Nutrition Examination Survey. J Public Health (Oxf) 2014 Feb 25; doi: 10.1093/pubmed/fdu012. [Epub]. http://dx.doi.org/10.1093/pubmed/fdu012. [DOI] [PubMed] [Google Scholar]
  • 17.Kweon S, Kim Y, Jang MJ, et al. Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES) Int J Epidemiol. 2014;43:69–77. doi: 10.1093/ije/dyt228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502. [PubMed] [Google Scholar]
  • 19.Castelli WP. Cholesterol and lipids in the risk of coronary artery disease--the Framingham Heart Study. Can J Cardiol. 1988;4(Suppl A):5A–10A. [PubMed] [Google Scholar]
  • 20.Kosmas CE, Christodoulidis G, Cheng JW, Vittorio TJ, Lerakis S. High-density lipoprotein functionality in coronary artery disease. Am J Med Sci. 2014;347:504–508. doi: 10.1097/MAJ.0000000000000231. [DOI] [PubMed] [Google Scholar]
  • 21.Assmann G, Schulte H, von Eckardstein A, Huang Y. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis. 1996;124:S11–S20. doi: 10.1016/0021-9150(96)05852-2. [DOI] [PubMed] [Google Scholar]
  • 22.Carroll MD, Kit BK, Lacher DA, Shero ST, Mussolino ME. Trends in lipids and lipoproteins in US adults, 1988-2010. JAMA. 2012;308:1545–1554. doi: 10.1001/jama.2012.13260. [DOI] [PubMed] [Google Scholar]
  • 23.Yano Y, Irie N, Homma Y, et al. High density lipoprotein cholesterol levels in the Japanese. Atherosclerosis. 1980;36:173–181. doi: 10.1016/0021-9150(80)90226-9. [DOI] [PubMed] [Google Scholar]
  • 24.Turley ML, Skeaff CM, Mann JI, Cox B. The effect of a low-fat, high-carbohydrate diet on serum high density lipoprotein cholesterol and triglyceride. Eur J Clin Nutr. 1998;52:728–732. doi: 10.1038/sj.ejcn.1600634. [DOI] [PubMed] [Google Scholar]
  • 25.Feinleib M, Garrison RJ, Fabsitz R, et al. The NHLBI twin study of cardiovascular disease risk factors: methodology and summary of results. Am J Epidemiol. 1977;106:284–285. doi: 10.1093/oxfordjournals.aje.a112464. [DOI] [PubMed] [Google Scholar]
  • 26.Schaefer EJ, Levy RI, Ernst ND, Van Sant FD, Brewer HB., Jr The effects of low cholesterol, high polyunsaturated fat, and low fat diets on plasma lipid and lipoprotein cholesterol levels in normal and hypercholesterolemic subjects. Am J Clin Nutr. 1981;34:1758–1763. doi: 10.1093/ajcn/34.9.1758. [DOI] [PubMed] [Google Scholar]
  • 27.Sanders K, Johnson L, O'Dea K, Sinclair AJ. The effect of dietary fat level and quality on plasma lipoprotein lipids and plasma fatty acids in normocholesterolemic subjects. Lipids. 1994;29:129–138. doi: 10.1007/BF02537152. [DOI] [PubMed] [Google Scholar]
  • 28.Schaefer EJ, Lamon-Fava S, Cohn SD, et al. Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study. J Lipid Res. 1994;35:779–792. [PubMed] [Google Scholar]
  • 29.Granfone A, Campos H, McNamara JR, et al. Effects of estrogen replacement on plasma lipoproteins and apolipoproteins in postmenopausal, dyslipidemic women. Metabolism. 1992;41:1193–1198. doi: 10.1016/0026-0495(92)90008-x. [DOI] [PubMed] [Google Scholar]
  • 30.Hwang YC, Ahn HY, Jeong IK, Ahn KJ, Chung HY. Optimal range of triglyceride values to estimate serum low density lipoprotein cholesterol concentration in Korean adults: the Korea National Health and Nutrition Examination Survey, 2009. J Korean Med Sci. 2012;27:1530–1535. doi: 10.3346/jkms.2012.27.12.1530. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

kcj-45-141-s001.pdf (34.5KB, pdf)

Supplementary Table 1. Distribution of total cholesterol (mg/dL) by age, sex, menopausal status.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th 90th 95th
Male (n=8284)
 10-14 788 156.9 26.6 117 125 139 156 172 191 204
 15-19 566 151.1 27.3 114 121 133 147 167 184 196
 20-24 327 167.9 29.7 129 134 147 164 187 213 220
 25-29 431 179.1 31.4 129 141 158 177 198 222 234
 30-34 548 188.4 34.3 135 146 166 186 210 230 246
 35-39 765 193.8 33.4 143 153 171 192 213 239 255
 40-44 729 193.9 35.7 139 153 172 192 216 237 249
 45-49 617 196.9 37.9 140 151 174 193 218 242 260
 50-54 659 195.6 33.3 142 154 172 196 216 238 249
 55-59 631 192.1 36.8 134 146 168 190 215 235 255
 60-64 643 187.3 34.4 131 144 164 187 212 231 242
 65-69 554 184.0 32.7 134 144 163 183 203 226 240
 70-74 559 183.6 33.9 128 144 160 181 205 227 242
 75-79 339 179.8 33.9 125 140 159 178 196 224 243
 80+ 128 173.5 33.6 120 129 150 174 194 217 232
Premenopausal female (n=5841)
 10-14 675 163.8 25.3 125 133 147 163 178 198 210
 15-19 524 162.3 26.3 125 132 144 159 178 196 211
 20-24 470 167.2 28.5 124 133 148 164 184 203 216
 25-29 593 174.1 31.0 130 141 153 170 191 214 231
 30-34 790 176.9 32.9 129 139 154 174 195 220 236
 35-39 1039 180.3 32.6 135 142 158 178 200 219 233
 40-44 843 183.1 31.3 138 144 161 181 202 224 240
 45-49 633 194.2 33.2 143 153 173 192 214 235 253
 50-54 274 200.8 33.5 153 160 177 200 223 246 260
Postmenopausal female (n=3405)
 45-49 113 194.6 31.5 143 157 176 190 211 229 254
 50-54 578 208.9 35.9 155 167 186 207 226 255 274
 55-59 590 210.1 36.6 153 165 183 210 234 257 271
 60-64 540 206.8 35.6 148 161 183 207 230 250 266
 65-69 466 205.6 36.2 150 159 182 205 228 252 267
 70-74 542 201.4 36.5 142 156 177 200 223 248 265
 75-79 387 198.4 36.9 144 152 173 197 219 244 264
 80+ 189 197.5 35.7 145 156 170 196 217 243 264
kcj-45-141-s002.pdf (34.4KB, pdf)

Supplementary Table 2. Distribution of total cholesterol (mg/dL) by age, sex, menopausal status not excluding people taking lipid-lowering agents.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th 90th 95th
Male (n=8656)
 10-14 788 156.9 26.6 117 125 139 156 172 191 204
 15-19 566 151.1 27.3 114 121 133 147 167 184 196
 20-24 327 167.9 29.7 129 134 147 164 187 213 220
 25-29 432 179.2 31.6 129 141 158 178 198 222 234
 30-34 550 188.4 34.2 135 146 166 186 210 230 246
 35-39 773 193.7 33.4 142 153 170 192 213 239 255
 40-44 742 193.5 35.7 139 152 171 192 216 237 247
 45-49 640 196.3 38.6 139 150 173 192 218 242 261
 50-54 704 195.1 35.3 141 152 171 194 216 238 250
 55-59 691 190.0 37.6 131 142 166 188 214 235 254
 60-64 714 185.6 34.7 129 141 161 185 211 230 241
 65-69 621 181.4 33.0 128 141 161 181 200 224 238
 70-74 611 182.2 34.9 126 139 159 179 204 225 241
 75-79 360 178.6 33.9 126 139 157 178 196 222 240
 80+ 137 173.2 33.4 120 130 148 173 196 217 232
Premenopausal female (n=5869)
 10-14 675 163.8 25.3 125 133 147 163 178 198 210
 15-19 524 162.3 26.3 125 132 144 159 178 196 211
 20-24 470 167.2 28.5 124 133 148 164 184 203 216
 25-29 593 174.1 31.0 130 141 153 170 191 214 231
 30-34 790 176.9 32.9 129 139 154 174 195 220 236
 35-39 1043 180.3 32.5 136 142 158 178 199 219 233
 40-44 850 182.9 31.4 137 144 161 181 201 225 241
 45-49 645 193.6 33.4 143 152 172 192 213 234 253
 50-54 279 200.7 33.4 153 160 177 200 223 246 260
Postmenopausal female (n=3909)
 45-49 119 193.5 32.3 139 152 175 190 211 230 254
 50-54 617 207.6 36.2 154 164 184 206 226 255 273
 55-59 670 206.8 37.9 145 160 180 206 232 255 271
 60-64 648 202.7 36.5 144 155 177 201 226 248 263
 65-69 578 199.7 36.9 143 154 172 198 223 247 263
 70-74 638 197.9 37.1 138 150 173 197 221 247 264
 75-79 441 195.4 37.5 140 151 168 195 217 242 260
 80+ 198 197.2 35.7 144 156 170 196 216 243 269
kcj-45-141-s003.pdf (34.5KB, pdf)

Supplementary Table 3. Distribution of triglycerides (mg/dL) by age, sex, menopausal status.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th 90th 95th
Male (n=8284)
 10-14 788 77.9 44.3 30 36 47 66 96 138 169
 15-19 566 83.6 44.3 37 42 55 74 98 143 175
 20-24 327 94.9 53.7 39 45 60 84 109 167 207
 25-29 431 130.3 104.3 47 54 74 104 150 218 296
 30-34 548 143.7 100.6 49 57 81 114 182 252 306
 35-39 765 151.6 90.8 54 65 90 130 189 268 316
 40-44 729 161.7 98.4 58 69 92 137 205 287 332
 45-49 617 164.5 115.0 51 68 94 136 200 302 345
 50-54 659 164.7 100.7 58 67 96 138 202 302 355
 55-59 631 159.2 103.9 53 66 96 136 200 272 326
 60-64 643 143.3 84.2 49 59 83 125 180 254 316
 65-69 554 133.1 75.3 45 58 82 118 163 229 276
 70-74 559 128.8 71.8 49 56 77 111 161 225 275
 75-79 339 119.7 69.4 48 55 73 104 144 215 258
 80+ 128 105.7 48.6 51 55 67 99 132 166 209
Premenopausal female (n=5841)
 10-14 675 89.5 48.5 38 44 58 78 107 149 191
 15-19 524 77.4 40.4 34 41 51 68 91 126 156
 20-24 470 75.7 43.5 34 40 51 66 88 118 146
 25-29 593 85.5 57.9 34 39 53 69 100 145 195
 30-34 790 88.5 54.3 34 39 53 72 108 152 194
 35-39 1039 91.7 57.8 36 42 56 75 110 153 194
 40-44 843 94.8 55.0 41 47 59 80 116 159 197
 45-49 633 110.1 69.0 43 49 66 92 129 192 246
 50-54 274 108.8 58.2 46 51 68 93 135 191 221
Postmenopausal female (n=3405)
 45-49 113 113.4 75.0 38 46 62 89 144 198 310
 50-54 578 128.3 77.2 47 56 74 108 156 234 287
 55-59 590 128.6 77.0 46 58 77 110 164 215 268
 60-64 540 135.6 74.9 55 62 81 116 167 241 274
 65-69 466 142.8 75.6 55 65 86 126 180 258 293
 70-74 542 138.6 79.6 53 63 88 123 175 230 263
 75-79 387 134.0 67.6 57 66 87 119 167 220 250
 80+ 189 141.0 67.4 63 72 94 124 170 249 290
kcj-45-141-s004.pdf (34.8KB, pdf)

Supplementary Table 4. Distribution of triglycerides (mg/dL) by age, sex, menopausal status not excluding people taking lipid-lowering agents.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th 90th 95th
Male (n=8656)
 10-14 788 77.9 44.3 30 36 47 66 96 138 169
 15-19 566 83.6 44.3 37 42 55 74 98 143 175
 20-24 327 94.9 53.7 39 45 60 84 109 167 207
 25-29 432 130.8 104.8 47 54 74 104 150 221 297
 30-34 550 144.2 100.7 49 57 81 115 182 253 306
 35-39 773 151.8 90.7 54 65 90 130 190 268 316
 40-44 742 162.6 99.0 58 69 93 137 206 288 335
 45-49 640 165.4 114.6 52 68 94.5 139 201 303 348
 50-54 704 166.6 102.2 58 68 96.5 139 205 302 355
 55-59 691 159.3 103.7 53 66 95 136 200 274 326
 60-64 714 145.8 84.6 50 59 86 128 186 253 316
 65-69 621 135.4 76.2 47 61 83 118 166 240 279
 70-74 611 129.7 71.7 49 57 77 111 162 226 274
 75-79 360 120.2 70.2 47.5 55 73 104 144 215 258
 80+ 137 106.2 49.4 51 55 66 98 132 166 210
Premenopausal female (n=5869)
 10-14 675 89.5 48.5 38 44 58 78 107 149 191
 15-19 524 77.4 40.4 34 41 51 68 91 126 156
 20-24 470 75.7 43.5 34 39.5 51 66 88 118 146
 25-29 593 85.5 57.9 34 39 53 69 100 145 195
 30-34 790 88.5 54.3 34 39 53 72 108 152 194
 35-39 1043 91.8 57.8 36 42 56 75 110 153 194
 40-44 850 95.5 55.7 41 47 60 80 116 160 198
 45-49 645 110.6 68.9 43 49 67 93 129 193 246
 50-54 279 109.2 57.9 46 51 68 94 135 191 221
Postmenopausal female (n=3909)
 45-49 119 117.2 76.1 38 46 64 93 159 229 310
 50-54 617 128.9 76.7 47 56 74 109 157 234 287
 55-59 670 130.2 76.8 46 57.5 78 112 167 221 270
 60-64 648 135.9 74.2 55 63 82 117 167 241 273
 65-69 578 143.3 73.8 56 66 89 126 180 252 293
 70-74 638 137.7 77.4 51 63 86 123 175 230 263
 75-79 441 132.8 67.1 56 66 87 118 164 218 250
 80+ 198 141.9 66.7 63 74 95 125 173 248 290
kcj-45-141-s005.pdf (34.2KB, pdf)

Supplementary Table 5. Distribution of high density lipoprotein-cholesterol (mg/dL) by age, sex, menopausal status.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th 90th 95th
Male (n=8284)
 10-14 788 54.4 10.9 37 41 47 53 62 69 74
 15-19 566 50.3 9.7 36 39 44 49 56 63 68
 20-24 327 53.2 11.6 38 40 45 52 59 69 74
 25-29 431 50.5 11.5 35 38 42 49 57 65 71
 30-34 548 49.4 11.1 34 37 41 48 56 65 71
 35-39 765 49.8 11.5 34 37 42 48 56 65 70
 40-44 729 48.7 10.8 34 36 40 48 55 63 69
 45-49 617 48.5 11.5 33 36 41 47 55 62 69
 50-54 659 49.4 12.2 34 36 41 47 56 65 73
 55-59 631 48.9 12.2 33 35 40 47 55 65 73
 60-64 643 50.0 13.1 34 36 40 48 57 67 76
 65-69 554 48.9 12.9 32 35 40 46.5 56 66 74
 70-74 559 48.9 12.7 32 34 40 47 56 65 72
 75-79 339 48.6 12.5 31 34 40 47 55 65 72
 80+ 128 47.6 12.9 30 32 38 44 57 69 72
Premenopausal female (n=5841)
 10-14 675 54.7 10.5 39 42 47 54 61 68 73
 15-19 524 57.0 10.9 40 44 49.5 56 64 70 75
 20-24 470 59.9 12.9 42 46 51 58 67 77 83
 25-29 593 60.0 13.0 40 43 51 59 68 77 82
 30-34 790 58.6 13.1 39 42 49 58 67 76 81
 35-39 1039 57.4 12.2 39 43 49 57 65 73 79
 40-44 843 55.9 12.7 39 42 47 55 63 71 77
 45-49 633 56.6 11.8 39 43 48 56 64 72 78
 50-54 274 55.9 12.9 37 40 47 54 63 71 80
Postmenopausal female (n=3405)
 45-49 113 55.2 12.7 34 38 46 56 63 70 76
 50-54 578 56.0 13.2 38 40 47 55 63 73 79
 55-59 590 53.4 11.9 37 39 44 52 61 69 73
 60-64 540 52.1 12.3 35 37 43 51 59 69 75
 65-69 466 51.6 11.4 35 38 44 50 59 67 71
 70-74 542 50.7 12.1 34 37 42 49 57 66 73
 75-79 387 50.0 11.3 33 36 42 49 57 64 69
 80+ 189 47.9 10.4 34 36 40 47 54 61 68
kcj-45-141-s006.pdf (34.4KB, pdf)

Supplementary Table 6. Distribution of high density lipoprotein-cholesterol (mg/dL) by age, sex, menopausal status not excluding people taking lipid-lowering agents.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th> 90th 95th
Male (n=8656)
 10-14 788 54.4 10.9 37 41 47 53 62 69 74
 15-19 566 50.3 9.7 36 39 44 49 56 63 68
 20-24 327 53.2 11.6 38 40 45 52 59 69 74
 25-29 432 50.4 11.5 35 38 42 49 57 65 71
 30-34 550 49.4 11.1 34 37 41 48 56 65 71
 35-39 773 49.7 11.4 34 37 42 48 56 65 70
 40-44 742 48.8 10.9 34 36 41 48 55 63 69
 45-49 640 48.4 11.4 33 36 41 47 55 62 69
 50-54 704 49.3 12.1 34 36 41 47 56 65 71
 55-59 691 49.0 12.2 33 36 41 47 55 65 73
 60-64 714 49.8 12.9 34 35 41 48 56 67 75
 65-69 621 48.8 12.7 32 35 40 47 56 66 72
 70-74 611 49.0 12.7 32 34 40 46 56 66 72
 75-79 360 48.5 12.5 31 34 40 47 55 65 72
 80+ 137 48.2 13.0 30 33 38 46 57 69 72
Premenopausal female (n=5869)
 10-14 675 54.7 10.5 39 42 47 54 61 68 73
 15-19 524 57.0 10.9 40 44 50 56 64 70 75
 20-24 470 59.9 12.9 42 46 51 58 67 77 83
 25-29 593 60.0 13.0 40 43 51 59 68 77 82
 30-34 790 58.6 13.1 39 42 49 58 67 76 81
 35-39 1043 57.4 12.2 39 43 49 57 65 73 79
 40-44 850 55.8 12.7 38 41 46 55 63 71 77
 45-49 645 56.5 11.8 39 43 48 56 64 72 77
 50-54 279 56.0 12.9 37 40 47 54 63 72 80
Postmenopausal female (n=3909)
 45-49 119 54.5 12.8 34 38 45 56 63 70 76
 50-54 617 56.1 13.2 38 41 47 55 63 73 79
 55-59 670 53.3 12.0 36 39 44 52 61 69 73
 60-64 648 52.4 12.4 35 37 43 51 60 69 75
 65-69 578 51.6 11.3 35 38 43 50 59 67 71
 70-74 638 51.1 12.5 33 37 43 49 58 67 73
 75-79 441 50.1 11.5 33 36 42 50 57 64 70
 80+ 198 48.0 10.2 34 36 40 47 54 61 68
kcj-45-141-s007.pdf (34.5KB, pdf)

Supplementary Table 7. Distribution of low density lipoprotein-cholesterol (mg/dL) by age, sex, menopausal status.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th 90th 95th
Male (n=8284)
 10-14 788 86.9 22.4 53 61 72 85 100 116 126
 15-19 566 84.1 24.0 50 57 69 82 98 113 124
 20-24 327 95.7 26.2 60 65 76 91 111 131 145
 25-29 431 103.6 28.0 60 67 86 103 120 140 153
 30-34 548 111.2 31.4 67 74 91 110 128 147 163
 35-39 765 114.3 30.2 68 78 94 113 133 154 168
 40-44 729 113.4 32.0 64 75 92 114 132 154 166
 45-49 617 116.4 34.3 63 75 94 116 137 156 174
 50-54 659 114.1 31.6 65 77 91 114 133 155 168
 55-59 631 111.9 33.8 60 71 91 109 132 155 170
 60-64 643 108.9 32.4 55 68 88 107 130 153 164
 65-69 554 108.7 30.6 56 71 89 109 127 147 159
 70-74 559 109.0 31.1 59 71 87 108 129 146 162
 75-79 339 107.3 31.1 57 67 88 107 127 147 160
 80+ 128 104.7 29.2 60 66 83 104 124 142 159
Premenopausal female (n=5841)
 10-14 675 91.2 21.9 58 64 77 89 105 121 130
 15-19 524 89.9 22.4 58 63 74 88 102 119 130
 20-24 470 92.1 24.2 57 64 76 89 106 123 134
 25-29 593 97.1 25.9 61 69 81 93 110 131 144
 30-34 790 100.7 27.2 63 68 81 97 117 135 149
 35-39 1039 104.6 28.2 65 73 85 102 121 141 154
 40-44 843 108.3 26.6 68 75 89 107 124 144 157
 45-49 633 115.8 29.7 72 80 95 115 132 151 165
 50-54 274 123.1 28.3 78 89 103 123 140 160 175
Postmenopausal female (n=3405)
 45-49 113 116.7 29.8 68 86 97 115 134 151 176
 50-54 578 127.4 31.6 78 90 106 126 144 168 183
 55-59 590 131.0 33.0 78 89 109 130 154 173 188
 60-64 540 127.6 31.9 75 86 105 127 148 168 181
 65-69 466 125.5 32.4 76 83 104 125 145 168 180
 70-74 542 123.1 32.4 70 82 101 123 146 165 177
 75-79 387 121.7 33.2 72 81 98 119 143 164 178
 80+ 189 121.4 32.7 71 81 98 120 138 166 185
kcj-45-141-s008.pdf (34.7KB, pdf)

Supplementary Table 8. Distribution of low density lipoprotein-cholesterol (mg/dL) by age, sex, menopausal status not excluding people taking lipid-lowering agents.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th 90th 95th
Male (n=8656)
 10-14 788 86.9 22.4 53 61 72 85 100 116 126
 15-19 566 84.1 24.0 50 57 69 82 98 113 124
 20-24 327 95.7 26.2 60 65 76 91 111 131 145
 25-29 432 103.7 28.0 60 67 86 103 120 140 153
 30-34 550 111.2 31.3 67 74 91 110 128 147 163
 35-39 773 114.1 30.3 68 78 94 113 133 154 168
 40-44 742 112.8 32.1 64 73 90 113 132 153 166
 45-49 640 115.8 35.0 61 74 92 115 136 156 175
 50-54 704 113.3 32.9 65 75 90 112 133 155 168
 55-59 691 109.7 34.2 58 69 88 108 130 154 169
 60-64 714 106.9 32.9 52 63 84 105 129 151 162
 65-69 621 105.8 31.2 54 67 85 106 125 146 157
 70-74 611 107.3 31.8 57 69 85 107 127 146 162
 75-79 360 106.2 31.3 57 66 83 105 126 147 157
 80+ 137 103.8 29.4 59 65 80 103 123 142 159
Premenopausal female (n=5869)
 10-14 675 91.2 21.9 58 64 77 89 105 121 130
 15-19 524 89.9 22.4 58 63 74 88 102 119 130
 20-24 470 92.1 24.2 57 64 76 89 106 123 134
 25-29 593 97.1 25.9 61 69 81 93 110 131 144
 30-34 790 100.7 27.2 63 68 81 97 117 135 149
 35-39 1043 104.6 28.2 65 73 85 102 121 140 153
 40-44 850 108.1 26.7 68 75 89 107 124 144 157
 45-49 645 115.2 30.0 71 79 95 114 132 150 164
 50-54 279 122.9 28.6 78 89 102 122 140 161 175
Postmenopausal female (n=3909)
 45-49 119 115.6 30.7 61 79 95 114 134 155 176
 50-54 617 125.9 32.2 75 86 105 124 144 167 183
 55-59 670 127.5 34.7 74 82 104 127 152 172 187
 60-64 648 123.1 33.0 72 81 99 122 146 165 176
 65-69 578 119.4 33.9 67 76 94 118 142 163 177
 70-74 638 119.3 33.2 67 76 97 118 142 163 177
 75-79 441 118.8 33.5 70 78 94 117 140 160 176
 80+ 198 120.8 32.9 71 76 98 120 137 166 188
kcj-45-141-s009.pdf (34.4KB, pdf)

Supplementary Table 9. Distribution of total cholesterol/high density lipoprotein-cholesterol ratio by age, sex, menopausal status.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th> 90th 95th
Male (n=8284)
 10-14 788 2.97 0.65 2.10 2.23 2.50 2.85 3.33 3.89 4.19
 15-19 566 3.09 0.72 2.17 2.28 2.62 2.98 3.43 3.97 4.44
 20-24 327 3.28 0.87 2.14 2.32 2.68 3.12 3.74 4.36 4.98
 25-29 431 3.71 1.01 2.30 2.52 2.98 3.57 4.31 5.08 5.63
 30-34 548 3.99 1.10 2.41 2.67 3.20 3.84 4.65 5.50 5.88
 35-39 765 4.08 1.10 2.48 2.72 3.26 4.02 4.76 5.52 6.06
 40-44 729 4.16 1.13 2.56 2.79 3.35 4.05 4.87 5.65 6.10
 45-49 617 4.24 1.12 2.61 2.91 3.45 4.14 4.92 5.74 6.13
 50-54 659 4.16 1.09 2.59 2.87 3.36 4.05 4.79 5.62 6.13
 55-59 631 4.12 1.13 2.44 2.75 3.30 4.00 4.78 5.56 6.08
 60-64 643 3.94 1.06 2.43 2.65 3.12 3.84 4.66 5.33 5.72
 65-69 554 3.96 1.06 2.40 2.60 3.18 3.89 4.72 5.37 5.74
 70-74 559 3.96 1.13 2.45 2.65 3.08 3.84 4.64 5.43 5.96
 75-79 339 3.90 1.09 2.40 2.61 3.05 3.74 4.58 5.30 5.97
 80+ 128 3.85 1.13 2.35 2.54 3.05 3.71 4.25 5.47 6.48
Premenopausal female (n=5841)
 10-14 675 3.08 0.66 2.26 2.41 2.61 2.97 3.40 3.91 4.35
 15-19 524 2.93 0.68 2.09 2.21 2.49 2.81 3.23 3.77 4.19
 20-24 470 2.88 0.67 2.07 2.21 2.43 2.78 3.17 3.69 4.26
 25-29 593 3.01 0.78 2.08 2.24 2.52 2.84 3.34 4.00 4.53
 30-34 790 3.14 0.78 2.16 2.28 2.56 2.98 3.56 4.15 4.70
 35-39 1039 3.25 0.82 2.27 2.41 2.66 3.08 3.66 4.35 4.84
 40-44 843 3.40 0.80 2.32 2.47 2.81 3.27 3.88 4.50 4.85
 45-49 633 3.56 0.88 2.40 2.57 2.91 3.41 4.07 4.71 5.23
 50-54 274 3.72 0.85 2.51 2.71 3.09 3.62 4.26 4.93 5.31
Postmenopausal female (n=3405)
 45-49 113 3.69 0.91 2.39 2.56 3.02 3.61 4.23 4.87 5.49
 50-54 578 3.90 1.03 2.56 2.74 3.11 3.70 4.46 5.36 5.91
 55-59 590 4.08 0.99 2.59 2.89 3.42 3.97 4.66 5.32 5.85
 60-64 540 4.14 1.02 2.63 2.86 3.32 4.08 4.85 5.57 5.96
 65-69 466 4.15 1.04 2.61 2.90 3.38 4.03 4.76 5.63 6.07
 70-74 542 4.15 1.08 2.59 2.80 3.33 4.06 4.88 5.53 6.03
 75-79 387 4.14 1.09 2.68 2.91 3.39 4.02 4.73 5.59 6.03
 80+ 189 4.27 1.03 2.84 3.03 3.50 4.16 4.90 5.60 6.03
kcj-45-141-s010.pdf (34.5KB, pdf)

Supplementary Table 10. Distribution of total cholesterol/high density lipoprotein-cholesterol ratio by age, sex, menopausal status not excluding people taking lipid-lowering agents.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th 90th 95th
Male (n=8656)
 10-14 788 3.0 0.6 2.10 2.23 2.50 2.85 3.33 3.89 4.19
 15-19 566 3.1 0.7 2.17 2.28 2.62 2.98 3.43 3.97 4.44
 20-24 327 3.3 0.9 2.14 2.32 2.68 3.12 3.74 4.36 4.98
 25-29 432 3.7 1.0 2.30 2.52 2.98 3.57 4.32 5.12 5.64
 30-34 550 4.0 1.1 2.41 2.67 3.20 3.84 4.65 5.48 5.88
 35-39 773 4.1 1.1 2.48 2.72 3.27 4.02 4.76 5.51 6.06
 40-44 742 4.1 1.1 2.56 2.80 3.33 4.04 4.86 5.62 6.10
 45-49 640 4.2 1.1 2.61 2.90 3.45 4.13 4.89 5.73 6.13
 50-54 704 4.2 1.2 2.57 2.87 3.34 4.04 4.77 5.62 6.13
 55-59 691 4.1 1.1 2.40 2.71 3.25 3.94 4.74 5.51 6.06
 60-64 714 3.9 1.1 2.42 2.63 3.07 3.82 4.66 5.37 5.72
 65-69 621 3.9 1.1 2.37 2.58 3.14 3.81 4.67 5.31 5.72
 70-74 611 3.9 1.1 2.40 2.62 3.06 3.81 4.60 5.36 5.93
 75-79 360 3.9 1.1 2.40 2.58 3.02 3.72 4.58 5.32 5.99
 80+ 137 3.8 1.1 2.32 2.52 3.03 3.62 4.23 5.32 6.48
Premenopausal female (n=5869)
 10-14 675 3.1 0.7 2.26 2.41 2.61 2.97 3.40 3.91 4.35
 15-19 524 2.9 0.7 2.09 2.21 2.49 2.81 3.23 3.77 4.19
 20-24 470 2.9 0.7 2.07 2.21 2.43 2.78 3.17 3.69 4.26
 25-29 593 3.0 0.8 2.08 2.24 2.52 2.84 3.34 4.00 4.53
 30-34 790 3.1 0.8 2.16 2.28 2.56 2.98 3.56 4.15 4.70
 35-39 1043 3.3 0.8 2.27 2.41 2.66 3.08 3.66 4.35 4.84
 40-44 850 3.4 0.8 2.31 2.47 2.81 3.27 3.88 4.51 4.87
 45-49 645 3.6 0.9 2.39 2.57 2.91 3.40 4.07 4.71 5.16
 50-54 279 3.7 0.9 2.50 2.69 3.08 3.61 4.26 4.95 5.31
Postmenopausal female (n=3909)
 45-49 119 3.7 1.0 2.39 2.56 3.02 3.61 4.23 5.04 5.56
 50-54 617 3.9 1.0 2.51 2.70 3.08 3.66 4.44 5.36 5.90
 55-59 670 4.0 1.0 2.57 2.82 3.33 3.91 4.60 5.29 5.83
 60-64 648 4.0 1.0 2.55 2.79 3.24 3.95 4.72 5.44 5.85
 65-69 578 4.0 1.0 2.52 2.79 3.25 3.89 4.66 5.54 5.90
 70-74 638 4.1 1.1 2.49 2.74 3.22 3.97 4.78 5.50 5.98
 75-79 441 4.1 1.1 2.64 2.86 3.30 3.91 4.63 5.46 5.91
 80+ 198 4.3 1.0 2.84 3.06 3.48 4.14 4.88 5.54 6.03
kcj-45-141-s011.pdf (34.4KB, pdf)

Supplementary Table 11. Distribution of low density lipoprotein-cholesterol/high density lipoprotein-cholesterol ratio by age, sex, menopausal status.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th 90th 95th
Male (n=8284)
 10-14 788 1.66 0.52 0.91 1.04 1.29 1.59 1.97 2.38 2.62
 15-19 566 1.74 0.62 0.92 1.05 1.34 1.65 2.02 2.50 2.86
 20-24 327 1.89 0.70 0.99 1.12 1.40 1.77 2.28 2.75 3.14
 25-29 431 2.14 0.78 1.01 1.22 1.59 2.05 2.59 3.19 3.61
 30-34 553 2.34 0.86 1.03 1.37 1.76 2.23 2.82 3.33 3.81
 35-39 786 2.39 0.87 1.11 1.38 1.80 2.31 2.94 3.46 3.93
 40-44 740 2.41 0.88 1.14 1.38 1.81 2.34 2.97 3.52 3.95
 45-49 626 2.48 0.90 1.13 1.43 1.84 2.42 3.02 3.68 4.00
 50-54 673 2.39 0.89 1.07 1.42 1.79 2.33 2.88 3.59 4.07
 55-59 637 2.40 0.92 1.05 1.29 1.76 2.32 2.91 3.57 3.94
 60-64 648 2.29 0.86 1.05 1.29 1.63 2.22 2.82 3.48 3.79
 65-69 558 2.34 0.87 0.95 1.28 1.74 2.26 2.89 3.49 3.81
 70-74 563 2.37 0.92 1.10 1.30 1.70 2.27 2.91 3.62 3.97
 75-79 341 2.34 0.87 1.08 1.27 1.71 2.27 2.89 3.48 3.88
 80+ 129 2.33 0.93 1.16 1.22 1.68 2.26 2.73 3.58 4.18
Premenopausal female (n=5841)
 10-14 675 1.72 0.52 1.01 1.15 1.37 1.64 2.00 2.39 2.68
 15-19 524 1.64 0.54 0.92 1.02 1.28 1.54 1.92 2.34 2.63
 20-24 470 1.61 0.56 0.88 1.00 1.22 1.54 1.88 2.29 2.79
 25-29 593 1.70 0.63 0.92 1.05 1.29 1.60 2.02 2.44 2.81
 30-34 790 1.80 0.63 0.97 1.10 1.35 1.72 2.17 2.59 3.04
 35-39 1039 1.91 0.67 1.05 1.19 1.44 1.80 2.23 2.81 3.12
 40-44 843 2.03 0.65 1.12 1.27 1.56 1.95 2.40 2.89 3.23
 45-49 633 2.13 0.71 1.13 1.33 1.63 2.05 2.55 3.05 3.44
 50-54 274 2.29 0.67 1.32 1.47 1.79 2.21 2.78 3.21 3.42
Postmenopausal female (n=3405)
 45-49 113 2.22 0.70 1.14 1.31 1.74 2.23 2.64 3.16 3.43
 50-54 578 2.39 0.80 1.32 1.47 1.80 2.29 2.85 3.44 3.76
 55-59 590 2.55 0.79 1.36 1.60 2.02 2.49 3.01 3.55 3.97
 60-64 540 2.57 0.81 1.31 1.54 1.94 2.55 3.10 3.68 3.99
 65-69 466 2.53 0.81 1.36 1.53 1.99 2.45 3.00 3.64 4.02
 70-74 542 2.55 0.86 1.29 1.50 1.90 2.47 3.09 3.67 4.14
 75-79 387 2.54 0.85 1.32 1.61 1.95 2.48 2.98 3.73 4.01
 80+ 189 2.63 0.84 1.40 1.68 2.04 2.50 3.21 3.68 4.14
kcj-45-141-s012.pdf (34.4KB, pdf)

Supplementary Table 12. Distribution of low density lipoprotein-cholesterol/high density lipoprotein-cholesterol ratio by age, sex, menopausal status not excluding people taking lipid-lowering agents.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th 90th 95th
Male (n=8656)
 10-14 788 1.7 0.5 0.91 1.04 1.29 1.59 1.97 2.38 2.62
 15-19 566 1.7 0.6 0.92 1.05 1.34 1.65 2.02 2.50 2.86
 20-24 327 1.9 0.7 0.99 1.12 1.40 1.77 2.28 2.75 3.14
 25-29 432 2.2 0.8 1.04 1.23 1.61 2.09 2.62 3.21 3.62
 30-34 550 2.4 0.9 1.11 1.41 1.80 2.27 2.84 3.33 3.85
 35-39 773 2.4 0.9 1.17 1.40 1.82 2.34 2.95 3.51 3.96
 40-44 742 2.4 0.9 1.19 1.40 1.83 2.35 2.95 3.50 3.91
 45-49 640 2.5 0.9 1.21 1.47 1.85 2.41 3.01 3.68 4.04
 50-54 704 2.4 0.9 1.18 1.45 1.83 2.33 2.92 3.59 4.07
 55-59 691 2.4 0.9 1.08 1.29 1.73 2.28 2.87 3.52 3.92
 60-64 714 2.3 0.9 0.98 1.29 1.60 2.19 2.81 3.44 3.79
 65-69 621 2.3 0.9 0.97 1.26 1.70 2.22 2.86 3.44 3.78
 70-74 611 2.3 0.9 1.08 1.28 1.65 2.22 2.89 3.58 3.93
 75-79 360 2.3 0.9 1.08 1.25 1.67 2.23 2.88 3.50 3.93
 80+ 137 2.3 0.9 1.14 1.22 1.65 2.19 2.73 3.55 4.18
Premenopausal female (n=5869)
 10-14 675 1.7 0.5 1.01 1.15 1.37 1.64 2.00 2.39 2.68
 15-19 524 1.6 0.5 0.92 1.02 1.28 1.54 1.92 2.34 2.63
 20-24 470 1.6 0.6 0.88 1.00 1.22 1.54 1.88 2.29 2.79
 25-29 593 1.7 0.6 0.92 1.05 1.29 1.60 2.02 2.44 2.81
 30-34 790 1.8 0.6 0.97 1.10 1.35 1.72 2.17 2.59 3.04
 35-39 1043 1.9 0.7 1.05 1.19 1.44 1.80 2.23 2.80 3.12
 40-44 850 2.0 0.7 1.12 1.26 1.56 1.95 2.40 2.89 3.25
 45-49 645 2.1 0.7 1.11 1.33 1.63 2.03 2.54 3.05 3.43
 50-54 279 2.3 0.7 1.28 1.41 1.79 2.21 2.78 3.23 3.43
Postmenopausal female (n=3909)
 45-49 119 2.2 0.8 1.14 1.31 1.74 2.20 2.64 3.23 3.46
 50-54 617 2.4 0.8 1.26 1.44 1.77 2.26 2.83 3.44 3.76
 55-59 670 2.5 0.8 1.26 1.46 1.91 2.43 2.95 3.53 3.90
 60-64 648 2.5 0.8 1.24 1.41 1.84 2.42 3.00 3.60 3.93
 65-69 578 2.4 0.8 1.21 1.42 1.83 2.30 2.91 3.48 3.97
 70-74 638 2.5 0.9 1.20 1.40 1.80 2.40 2.99 3.60 4.09
 75-79 441 2.5 0.9 1.27 1.51 1.86 2.42 2.92 3.53 3.96
 80+ 198 2.6 0.8 1.40 1.66 2.02 2.47 3.20 3.67 4.14
kcj-45-141-s013.pdf (34.4KB, pdf)

Supplementary Table 13. Distribution of triglycerides/high density lipoprotein-cholesterol ratio by age, sex, menopausal status.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th 90th 95th
Male (n=8284)
 10-14 788 1.55 1.12 0.50 0.60 0.85 1.20 1.85 3.14 3.84
 15-19 566 1.76 1.11 0.68 0.79 1.05 1.46 2.12 3.09 3.84
 20-24 327 1.96 1.42 0.63 0.76 1.03 1.58 2.30 3.64 4.88
 25-29 431 2.88 2.90 0.73 0.94 1.36 2.06 3.42 5.35 7.07
 30-34 553 3.33 2.95 0.86 1.05 1.51 2.35 4.25 6.33 8.66
 35-39 786 3.65 3.13 0.90 1.19 1.71 2.75 4.41 7.17 9.22
 40-44 740 3.81 2.99 1.02 1.26 1.79 2.95 4.88 7.56 9.57
 45-49 626 3.90 3.36 0.86 1.22 1.88 2.98 4.71 7.71 9.72
 50-54 673 3.95 3.33 0.96 1.22 1.84 3.06 4.79 7.66 10.45
 55-59 637 3.71 3.07 0.91 1.16 1.88 2.89 4.63 6.53 8.70
 60-64 648 3.27 2.41 0.78 1.02 1.53 2.54 4.27 6.51 8.20
 65-69 558 3.21 3.03 0.76 1.02 1.57 2.59 3.86 5.86 7.39
 70-74 563 2.99 2.10 0.81 1.00 1.45 2.45 3.81 5.91 7.33
 75-79 341 2.88 2.48 0.78 0.93 1.43 2.27 3.30 5.28 7.65
 80+ 129 2.70 2.64 0.82 0.93 1.32 2.07 3.00 5.36 5.96
Premenopausal female (n=5841)
 10-14 675 1.78 1.31 0.62 0.72 1.00 1.40 2.14 3.14 4.13
 15-19 524 1.47 1.04 0.55 0.63 0.86 1.20 1.70 2.38 3.26
 20-24 470 1.37 1.05 0.51 0.61 0.82 1.14 1.56 2.32 2.72
 25-29 593 1.56 1.29 0.48 0.58 0.84 1.16 1.75 3.05 4.14
 30-34 790 1.67 1.34 0.51 0.62 0.85 1.28 2.00 3.05 3.90
 35-39 1039 1.75 1.42 0.55 0.67 0.92 1.35 2.07 3.15 4.16
 40-44 843 1.86 1.36 0.62 0.75 0.98 1.48 2.27 3.36 4.24
 45-49 633 2.12 1.58 0.64 0.77 1.10 1.67 2.60 4.13 5.39
 50-54 274 2.15 1.48 0.69 0.83 1.10 1.78 2.62 3.85 5.48
Postmenopausal female (n=3405)
 45-49 113 2.35 2.12 0.65 0.83 1.11 1.51 2.88 5.35 7.65
 50-54 578 2.57 2.02 0.71 0.88 1.28 1.91 3.18 5.16 6.67
 55-59 590 2.68 2.04 0.73 0.92 1.35 2.12 3.43 5.06 6.26
 60-64 540 2.89 2.02 0.82 1.02 1.43 2.36 3.67 5.55 7.01
 65-69 466 3.07 2.10 0.88 1.03 1.53 2.45 4.06 5.98 7.00
 70-74 542 3.02 2.18 0.86 1.11 1.64 2.45 3.95 5.83 6.88
 75-79 387 2.98 2.06 0.93 1.05 1.61 2.39 3.70 5.44 7.12
 80+ 189 3.20 1.97 1.02 1.30 1.83 2.63 4.03 5.70 7.26
kcj-45-141-s014.pdf (34.5KB, pdf)

Supplementary Table 14. Distribution of triglycerides/high density lipoprotein-cholesterol ratio by age, sex, menopausal status not excluding people taking lipid-lowering agents.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th 90th 95th
Male (n=8656)
 10-14 788 1.6 1.1 0.50 0.60 0.85 1.20 1.85 3.14 3.84
 15-19 566 1.8 1.1 0.68 0.79 1.05 1.46 2.12 3.09 3.84
 20-24 327 2.0 1.4 0.63 0.76 1.03 1.58 2.30 3.64 4.88
 25-29 432 2.9 2.9 0.73 0.94 1.37 2.06 3.42 5.38 7.22
 30-34 550 3.2 2.8 0.86 1.05 1.49 2.33 4.21 6.26 8.43
 35-39 773 3.4 2.5 0.90 1.18 1.68 2.71 4.20 6.36 7.92
 40-44 742 3.7 2.8 1.02 1.27 1.79 2.91 4.81 7.09 8.68
 45-49 640 3.8 3.1 0.87 1.23 1.89 2.97 4.63 7.42 9.04
 50-54 704 3.8 2.8 0.96 1.22 1.85 3.05 4.71 7.24 9.00
 55-59 691 3.6 2.8 0.92 1.17 1.85 2.85 4.56 6.44 8.21
 60-64 714 3.3 2.4 0.80 1.03 1.59 2.57 4.27 6.45 8.15
 65-69 621 3.1 2.2 0.79 1.04 1.58 2.58 3.96 5.80 7.17
 70-74 611 3.0 2.0 0.81 1.02 1.47 2.43 3.78 5.65 7.11
 75-79 360 2.8 2.3 0.76 0.91 1.42 2.23 3.30 5.30 7.46
 80+ 137 2.5 1.7 0.82 0.93 1.29 2.02 2.98 5.16 5.96
Premenopausal female (n=5869)
 10-14 675 1.8 1.3 0.62 0.72 1.00 1.40 2.14 3.14 4.13
 15-19 524 1.5 1.0 0.55 0.63 0.86 1.20 1.70 2.38 3.26
 20-24 470 1.4 1.1 0.51 0.61 0.82 1.14 1.56 2.32 2.72
 25-29 593 1.6 1.3 0.48 0.58 0.84 1.16 1.75 3.05 4.14
 30-34 790 1.7 1.3 0.51 0.62 0.85 1.28 2.00 3.05 3.90
 35-39 1043 1.8 1.4 0.56 0.67 0.92 1.35 2.08 3.15 4.16
 40-44 850 1.9 1.4 0.62 0.76 0.99 1.49 2.28 3.46 4.36
 45-49 645 2.1 1.6 0.65 0.77 1.11 1.68 2.61 4.15 5.39
 50-54 279 2.2 1.5 0.69 0.83 1.10 1.78 2.67 3.90 5.48
Postmenopausal female (n=3909)
 45-49 119 2.5 2.2 0.65 0.83 1.11 1.51 3.14 5.79 7.65
 50-54 617 2.6 2.0 0.71 0.88 1.29 1.91 3.18 5.16 6.66
 55-59 670 2.7 2.0 0.73 0.92 1.35 2.16 3.44 5.08 6.39
 60-64 648 2.9 2.0 0.82 1.02 1.45 2.32 3.69 5.57 6.83
 65-69 578 3.1 2.0 0.89 1.07 1.57 2.50 4.02 5.94 7.02
 70-74 638 3.0 2.1 0.82 1.05 1.62 2.43 3.89 5.66 6.87
 75-79 441 2.9 2.0 0.93 1.10 1.61 2.38 3.63 5.32 7.12
 80+ 198 3.2 1.9 1.02 1.31 1.87 2.70 4.03 5.70 7.26
kcj-45-141-s015.pdf (34.6KB, pdf)

Supplementary Table 15. Distribution of non-high density lipoprotein-cholesterol (mg/dL) by age, sex, menopausal status.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th 90th 95th
Male (n=8284)
 10-14 788 102.5 24.8 65 74 85 100 118 134 144
 15-19 566 100.9 26.5 65 70 83 98 115 133 145
 20-24 327 114.7 29.8 74 81 92 109 133 153 170
 25-29 431 128.6 32.6 82 89 105 126 149 171 186
 30-34 553 139.4 35.7 84 95 116 139 163 182 195
 35-39 786 144.9 35.0 91 103 120 144 167 191 210
 40-44 740 146.1 37.0 90 102 122 144 169 191 203
 45-49 626 149.2 38.3 95 103 124 146 172 195 214
 50-54 673 147.1 34.2 96 106 124 146 168 191 205
 55-59 637 143.8 37.0 88 97 118 142 166 188 206
 60-64 648 137.5 33.8 83 94 113 136 160 181 196
 65-69 558 135.4 33.5 82 92 114 134 157 178 189
 70-74 563 135.2 35.2 82 95 110 133 156 179 195
 75-79 341 131.4 33.6 80 91 109 130 152 176 192
 80+ 129 126.1 32.5 77 84 102 124 142 171 185
Premenopausal female (n=5841)
 10-14 675 109.1 23.6 73 81 93 106 123 140 150
 15-19 524 105.4 25.3 69 76 88 102 119 137 153
 20-24 470 107.3 26.7 71 77 89 104 123 142 155
 25-29 593 114.1 29.8 75 83 95 110 129 151 171
 30-34 790 118.4 30.6 76 83 96 114 136 158 175
 35-39 1039 122.9 31.6 80 87 100 119 140 163 180
 40-44 843 127.2 29.6 83 92 107 125 144 167 180
 45-49 633 137.6 32.9 89 96 115 136 156 179 195
 50-54 274 144.8 31.4 97 104 121 144 166 184 200
Postmenopausal female (n=3405)
 45-49 113 139.4 30.8 96 104 116 140 158 171 194
 50-54 578 152.9 35.5 102 111 128 150 172 198 218
 55-59 590 156.7 35.3 100 112 132 156 180 203 217
 60-64 540 154.7 34.4 98 110 131 154 179 198 211
 65-69 466 154.0 35.6 97 109 128 154 177 200 210
 70-74 542 150.7 36.0 93 103 127 150 174 197 208
 75-79 387 148.4 36.0 94 102 125 148 167 191 209
 80+ 189 149.6 34.6 100 109 125 147 167 195 215
kcj-45-141-s016.pdf (34.8KB, pdf)

Supplementary Table 16. Distribution of non-high density lipoprotein-cholesterol (mg/dL) by age, sex, menopausal status not excluding people taking lipid-lowering agents.

Age Number Mean Standard deviation Percentiles
5th 10th 25th 50th 75th 90th 95th
Male (n=8656)
 10-14 788 102.5 24.8 65 74 85 100 118 134 144
 15-19 566 100.9 26.5 65 70 83 98 115 133 145
 20-24 327 114.7 29.8 74 81 92 109 133 153 170
 25-29 432 128.8 32.9 82 89 105 126 150 172 187
 30-34 550 139.0 35.3 84 95 116 139 163 182 194
 35-39 773 144.0 34.6 90 102 119 143 166 189 207
 40-44 742 144.8 36.3 90 102 122 143 167 190 202
 45-49 640 147.9 38.5 93 102 124 145 171 192 212
 50-54 704 145.9 35.5 94 103 122 144 167 191 205
 55-59 691 141.0 37.2 85 94 115 140 164 185 204
 60-64 714 135.8 34.3 81 89 110 134 159 181 193
 65-69 621 132.6 32.9 80 88 112 131 154 175 188
 70-74 611 133.2 34.5 79 93 108 131 155 178 194
 75-79 360 130.1 33.9 78 90 107 128 151 176 192
 80+ 137 125.0 32.5 77 82 101 124 142 168 185
Premenopausal female (n=5869)
 10-14 675 109.1 23.6 73 81 93 106 123 140 150
 15-19 524 105.4 25.3 69 76 88 102 119 137 153
 20-24 470 107.3 26.7 71 77 89 104 123 142 155
 25-29 593 114.1 29.8 75 83 95 110 129 151 171
 30-34 790 118.4 30.6 76 83 96 114 136 158 175
 35-39 1043 122.9 31.6 80 87 100 119 140 162 179
 40-44 850 127.1 29.8 82 92 106 125 143 168 181
 45-49 645 137.1 32.9 89 95 114 135 156 179 193
 50-54 279 144.7 31.5 97 103 120 144 166 186 200
Postmenopausal female (n=3909)
 45-49 119 139.0 31.7 93 100 114 139 158 175 194
 50-54 617 151.5 36.0 98 109 126 148 171 198 218
 55-59 670 153.5 36.7 96 106 127 152 177 203 217
 60-64 648 150.3 35.3 91 104 125 149 174 195 209
 65-69 578 148.1 36.4 90 102 122 145 172 197 208
 70-74 638 146.8 36.7 89 100 122 146 171 196 207
 75-79 441 145.3 36.3 91 99 120 144 165 189 206
 80+ 198 149.2 34.6 98 109 124 147 167 195 217

Articles from Korean Circulation Journal are provided here courtesy of The Korean Society of Cardiology

RESOURCES